Rank;Sourceid;Title;Type;Issn;SJR;SJR Best Quartile;H index;Total Docs. (2001);Total Docs. (3years);Total Refs.;Total Cites (3years);Citable Docs. (3years);Cites / Doc. (2years);Ref. / Doc.;Country;Region;Publisher;Coverage;Categories
1;21191;Pharmacological Reviews;journal;15210081, 00316997;12.716;Q1;241;22;66;7351;1862;65;23.55;334.14;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1949, 1951-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
2;19479;Annual Review of Pharmacology and Toxicology;journal;15454304, 03621642;10.621;Q1;210;33;65;4729;1432;64;21.29;143.3;United States;Northern America;Annual Reviews Inc.;1965-1973, 1975-2021;"Pharmacology (Q1); Toxicology (Q1)"
3;22321;Trends in Pharmacological Sciences;journal;18733735, 01656147;4.24;Q1;225;202;350;4593;2819;283;8.17;22.74;United Kingdom;Western Europe;Elsevier Ltd.;1979-2021;"Pharmacology (Q1); Toxicology (Q1)"
4;24032;Reviews of Physiology Biochemistry and Pharmacology;journal;16175786, 03034240;3.536;Q1;66;6;43;1620;276;43;5.82;270;Germany;Western Europe;Springer Verlag;1974-2008, 2012-2018;"Biochemistry (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Physiology (Q1); Physiology (medical) (Q1)"
5;21100456838;Cell Chemical Biology;journal;24519448, 24519456;3.065;Q1;190;104;363;4315;2010;336;5.87;41.49;United States;Northern America;Elsevier Inc.;2016-2021;"Biochemistry (Q1); Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
6;19963;Molecular Pharmacology;journal;15210111, 0026895X;2.793;Q1;202;349;907;13376;5216;905;5.49;38.33;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1965-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
7;21195;Pharmacology and Therapeutics;journal;1879016X, 01637258;2.763;Q1;211;55;189;9848;1361;187;5.89;179.05;United States;Northern America;Elsevier Inc.;1975-1977, 1979-1985, 1987-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
8;82448;Mutation Research - DNA Repair;journal;09218777;2.657;Q1;75;79;206;4123;851;204;4.48;52.19;Netherlands;Western Europe;Elsevier BV;1989-2001;"Genetics (Q1); Molecular Biology (Q1); Toxicology (Q1)"
9;13903;Cellular and Molecular Life Sciences;journal;1420682X, 14209071;2.575;Q1;233;183;547;16769;2341;533;4.39;91.63;Switzerland;Western Europe;Birkhauser Verlag Basel;1952, 1997-2021;"Cell Biology (Q1); Cellular and Molecular Neuroscience (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
10;26371;Natural Product Reports;journal;02650568, 14604752;2.341;Q1;188;34;115;7237;592;114;5.94;212.85;United Kingdom;Western Europe;Royal Society of Chemistry;1984-2021;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
11;19615;Antimicrobial Agents and Chemotherapy;journal;10986596, 00664804;2.334;Q1;269;659;1920;18292;9185;1829;4.76;27.76;United States;Northern America;American Society for Microbiology;1963-1970, 1972-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
12;24661;Critical Reviews in Toxicology;journal;15476898, 10408444;2.297;Q1;117;36;38;2962;281;37;6.96;82.28;United Kingdom;Western Europe;Informa Healthcare;1971-2021;Toxicology (Q1)
13;18017;Neuropsychopharmacology;journal;0893133X, 1470634X;2.239;Q1;227;182;427;9179;2109;397;4.68;50.43;United Kingdom;Western Europe;Nature Publishing Group;1987-2021;"Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
14;18148;Pain;journal;18726623, 03043959;2.08;Q1;269;223;748;9056;3737;683;4.88;40.61;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1975-2021;"Anesthesiology and Pain Medicine (Q1); Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1)"
15;23488;Current Medicinal Chemistry;journal;09298673, 1875533X;1.951;Q1;183;122;166;11854;929;154;5.79;97.16;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1994-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
16;20435;Neuropharmacology;journal;00283908, 18737064;1.9;Q1;176;229;631;9109;2510;629;3.97;39.78;United Kingdom;Western Europe;Elsevier Ltd.;1962-2021;"Cellular and Molecular Neuroscience (Q1); Pharmacology (Q1)"
17;25152;Journal of Toxicology and Environmental Health - Part B: Critical Reviews;journal;10937404, 15216950;1.898;Q1;89;10;35;1795;182;35;5.52;179.5;United Kingdom;Western Europe;Taylor and Francis Ltd.;1998-2021;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
18;130044;Pharmacogenetics and Genomics;journal;17446880, 17446872;1.843;-;144;94;248;3268;1169;246;4.57;34.77;United States;Northern America;Lippincott Williams and Wilkins Ltd.;2005-2021;"Genetics (Q1); Genetics (clinical) (Q1); Molecular Biology (Q1); Molecular Medicine (Q1)"
19;19034;Microbial Drug Resistance;journal;10766294, 19318448;1.791;Q1;72;43;122;1591;458;122;2.84;37;United States;Northern America;Mary Ann Liebert Inc.;1995-2021;"Immunology (Q1); Medicine (miscellaneous) (Q1); Microbiology (Q1); Microbiology (medical) (Q1); Pharmacology (Q1)"
20;15984;Journal of Molecular Medicine;journal;09462716, 14321440;1.789;Q1;146;119;336;5270;1233;318;3.33;44.29;Germany;Western Europe;Springer Verlag;1976-1978, 1980-1981, 1995-2021;"Drug Discovery (Q1); Genetics (clinical) (Q1); Molecular Medicine (Q1)"
21;23041;Journal of Medicinal Chemistry;journal;00222623, 15204804;1.66;Q1;276;496;1657;19999;7303;1557;4.46;40.32;United States;Northern America;American Chemical Society;1959-1961, 1963-2021;"Drug Discovery (Q1); Molecular Medicine (Q1)"
22;12455;Molecular Therapy;journal;15250024, 15250016;1.644;Q1;185;214;170;7336;769;135;4.52;34.28;United States;Northern America;Cell Press;2000-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Molecular Medicine (Q1); Pharmacology (Q1); Genetics (Q2); Molecular Biology (Q2)"
23;19907;Medicinal Research Reviews;journal;01986325, 10981128;1.632;Q1;134;28;74;3075;382;73;5.54;109.82;United States;Northern America;"John Wiley &amp; Sons Inc.";1981-2021;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
24;29099;Cancer Chemotherapy and Pharmacology, Supplement;journal;09439404;1.605;Q1;33;10;33;299;174;32;7.59;29.9;Germany;Western Europe;Springer Verlag;1994, 1996-2003;"Cancer Research (Q1); Oncology (Q1); Pharmacology (Q1)"
25;19427;Advances in Pharmacology;journal;15578925, 10543589;1.594;Q1;78;0;55;0;198;41;2.7;0;United States;Northern America;Academic Press Inc.;1962-1964, 1966-1973, 1975, 1977-1982, 1984, 1990-2000, 2004-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
26;20084;British Journal of Pharmacology;journal;14765381, 00071188;1.549;Q1;223;603;2113;23875;7522;2110;3.41;39.59;United States;Northern America;Wiley-Blackwell;1965-2021;Pharmacology (Q1)
27;23086;Journal of Pharmacology and Experimental Therapeutics;journal;15210103, 00223565;1.53;Q1;233;589;2014;21572;7769;2013;3.79;36.62;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1945-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
28;26514;Tetrahedron Letters;journal;00404039, 18733581;1.471;Q1;173;2281;7245;50842;17175;7243;2.44;22.29;United Kingdom;Western Europe;Elsevier Ltd.;1959-2021;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
29;26512;Tetrahedron;journal;14645416, 00404020;1.455;Q1;226;1128;3429;44264;8272;3415;2.41;39.24;United Kingdom;Western Europe;Elsevier Ltd.;1957-2021;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
30;20624;Clinical Pharmacokinetics;journal;11791926, 03125963;1.435;Q1;169;75;206;4310;1106;198;5.13;57.47;United Kingdom;Western Europe;Adis International Ltd;1976-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
31;21782;Psychopharmacology;journal;00333158, 14322072;1.42;Q1;202;336;1010;14966;3365;987;3.28;44.54;Germany;Western Europe;Springer Verlag;1959-2021;Pharmacology (Q1)
32;26795;Controlled Clinical Trials;journal;01972456;1.396;Q1;74;72;175;1450;407;148;1.51;20.14;Netherlands;Western Europe;Elsevier BV;1980-2004;Pharmacology (Q1)
33;22418;Journal of Antimicrobial Chemotherapy;journal;03057453, 14602091;1.388;Q1;203;376;1127;6829;3481;882;3.07;18.16;United Kingdom;Western Europe;Oxford University Press;1975-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
34;20063;Biochemical Pharmacology;journal;18732968, 00062952;1.337;Q1;206;368;1248;14847;4275;1217;3.45;40.35;United States;Northern America;Elsevier Inc.;1958-2021;"Biochemistry (Q1); Pharmacology (Q1)"
35;21455;Progress in Medicinal Chemistry;journal;00796468, 18757863;1.288;Q1;36;8;19;1459;54;6;3.23;182.38;Netherlands;Western Europe;Elsevier;1961-1963, 1965, 1967, 1969-2021;"Pharmacology (Q1); Molecular Medicine (Q2)"
36;24074;Helvetica Chimica Acta;journal;0018019X, 15222675;1.279;Q1;85;287;618;11111;1378;616;2.16;38.71;United States;Northern America;Wiley-Blackwell;1918-2021;"Biochemistry (Q1); Drug Discovery (Q1); Inorganic Chemistry (Q1); Organic Chemistry (Q1); Physical and Theoretical Chemistry (Q1); Catalysis (Q2)"
37;23010;Journal of Controlled Release;journal;18734995, 01683659;1.26;Q1;282;265;650;7559;2009;640;2.96;28.52;Netherlands;Western Europe;Elsevier;1984-2021;Pharmaceutical Science (Q1)
38;20659;Critical Reviews in Therapeutic Drug Carrier Systems;journal;07434863, 2162660X;1.244;Q1;76;16;40;2641;168;40;3.15;165.06;United States;Northern America;Begell House Inc.;1984-2021;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
39;7000153203;Journal of Studies on Alcohol and Drugs;journal;19371888, 19384114;1.234;Q1;129;98;319;4001;739;301;1.99;40.83;United States;Northern America;Alcohol Research Documentation, Inc.;2007-2021;"Health (social science) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
40;4400151701;Journal of Exposure Science and Environmental Epidemiology;journal;1559064X, 15590631;1.223;Q1;96;50;168;1554;311;165;1.83;31.08;United Kingdom;Western Europe;Nature Publishing Group;2006-2021;"Pollution (Q1); Public Health, Environmental and Occupational Health (Q1); Toxicology (Q1); Epidemiology (Q2)"
41;18922;Journal of Gene Medicine;journal;1099498X, 15212254;1.192;Q1;94;60;107;2388;436;107;4.11;39.8;United States;Northern America;John Wiley and Sons Ltd;1998-2021;"Drug Discovery (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
42;24649;Chemical Research in Toxicology;journal;15205010, 0893228X;1.183;Q1;163;190;535;7741;1743;531;3.16;40.74;United States;Northern America;American Chemical Society;1988-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
43;23053;Journal of Natural Products;journal;01633864, 15206025;1.175;Q1;147;398;1255;7301;2486;1253;1.94;18.34;United States;Northern America;American Chemical Society;1949, 1971, 1973, 1978-2021;"Analytical Chemistry (Q1); Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
44;20682;Current Pharmaceutical Design;journal;13816128, 18734286;1.153;Q1;166;115;219;13310;741;192;3.16;115.74;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1995-2021;"Drug Discovery (Q1); Pharmacology (Q1)"
45;24791;Alcoholism: Clinical and Experimental Research;journal;01456008, 15300277;1.149;Q1;159;298;983;12473;2619;964;2.37;41.86;United States;Northern America;Wiley-Blackwell;1977-2021;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
46;23916;Environmental Pollution;journal;02697491, 18736424;1.142;Q1;249;242;654;9742;1044;632;1.48;40.26;United Kingdom;Western Europe;Elsevier Ltd.;1970-1980, 1986-2022;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Pollution (Q1); Toxicology (Q1)"
47;21123;Pharmaceutical Research;journal;07248741, 1573904X;1.129;Q1;213;264;837;6668;2352;807;2.64;25.26;United States;Northern America;Springer New York;1984-2021;"Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Molecular Medicine (Q2)"
48;26380;Drug and Alcohol Dependence;journal;03768716;1.123;Q1;173;135;348;5104;1013;335;2.53;37.81;Ireland;Western Europe;Elsevier Ireland Ltd;1975-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
49;25125;Journal of Analytical Toxicology;journal;19452403, 01464760;1.118;Q1;78;119;346;2275;506;308;1.49;19.12;United States;Northern America;Preston Publications;1977-2021;"Analytical Chemistry (Q1); Chemical Health and Safety (Q1); Environmental Chemistry (Q1); Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
50;12584;Drug Metabolism Reviews;journal;10979883, 03602532;1.116;Q1;100;15;100;1823;304;100;2.99;121.53;United States;Northern America;Informa Healthcare;1972-2021;"Pharmacology (medical) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
51;24603;Archives of Environmental Contamination and Toxicology;journal;14320703, 00904341;1.095;Q1;115;139;425;5118;709;422;1.45;36.82;United States;Northern America;Springer New York;1973-2021;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Pollution (Q1); Toxicology (Q1)"
52;19409;Advanced Drug Delivery Reviews;journal;0169409X, 18728294;1.091;Q1;331;162;316;13200;1079;290;3.12;81.48;Netherlands;Western Europe;Elsevier;1987-2021;Pharmaceutical Science (Q1)
53;20082;British Journal of Clinical Pharmacology;journal;13652125, 03065251;1.091;Q1;153;186;617;4797;1685;566;2.49;25.79;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1974-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
54;16876;Bioconjugate Chemistry;journal;15204812, 10431802;1.087;Q1;177;137;373;4792;1190;371;3.16;34.98;United States;Northern America;American Chemical Society;1990-2021;"Bioengineering (Q1); Biomedical Engineering (Q1); Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
55;25222;Toxicology and Applied Pharmacology;journal;10960333, 0041008X;1.087;Q1;175;209;693;9348;1986;679;2.71;44.73;United States;Northern America;Academic Press Inc.;1959-2021;"Pharmacology (Q1); Toxicology (Q1)"
56;20626;Clinical Pharmacology and Therapeutics;journal;15326535, 00099236;1.074;Q1;195;499;820;3405;2127;774;2.14;6.82;United States;Northern America;Wiley-Blackwell;1960-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
57;110172;Progress in Drug Research;book series;0071786X;1.066;Q1;44;18;41;2860;128;37;2.11;158.89;Switzerland;Western Europe;Birkhauser Verlag Basel;1959-1966, 1968-1969, 1972-2003, 2005, 2007-2008, 2011, 2014-2018;"Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Molecular Medicine (Q2)"
58;21226;Drug Metabolism and Disposition;journal;00909556, 1521009X;1.037;Q1;182;249;648;8201;1982;646;3.12;32.94;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1973-2021;"Pharmaceutical Science (Q1); Pharmacology (Q1)"
59;25218;Toxicological Sciences;journal;10960929, 10966080;1.028;Q1;193;243;675;9684;1834;662;2.7;39.85;United Kingdom;Western Europe;Oxford University Press;1981-2021;Toxicology (Q1)
60;21237;Drug Safety;journal;01145916, 11791942;1.019;Q1;131;86;238;6344;955;231;3.96;73.77;United Kingdom;Western Europe;Adis International Ltd;1990-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1)"
61;24619;Journal of Computer-Aided Molecular Design;journal;15734951, 0920654X;0.991;Q1;104;75;148;3318;468;148;3.34;44.24;Netherlands;Western Europe;Springer Netherlands;1987-2021;"Computer Science Applications (Q1); Drug Discovery (Q1); Physical and Theoretical Chemistry (Q2)"
62;23109;Journal of Psychopharmacology;journal;14617285, 02698811;0.978;Q1;121;51;223;1870;579;196;2.05;36.67;United Kingdom;Western Europe;SAGE Publications Ltd;1987-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
63;14144;Experimental and Clinical Psychopharmacology;journal;19362293, 10641297;0.967;Q1;95;52;167;2069;324;166;1.49;39.79;United States;Northern America;American Psychological Association;1993-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
64;20427;Naunyn-Schmiedeberg's Archives of Pharmacology;journal;00281298, 14321912;0.965;Q1;93;163;507;5801;1206;503;2.43;35.59;Germany;Western Europe;Springer Verlag;1969-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
65;21744;Planta Medica;journal;14390221, 00320943;0.959;Q1;122;230;679;3840;1071;646;1.51;16.7;Germany;Western Europe;Georg Thieme Verlag;1961, 1965-2021;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Analytical Chemistry (Q2); Molecular Medicine (Q2)"
66;27823;Alimentary Pharmacology and Therapeutics, Supplement;journal;09530673;0.952;Q1;66;10;100;431;342;88;3.42;43.1;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1991, 1993-2005;"Pharmacology (medical) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
67;23079;Journal of Pharmaceutical Sciences;journal;15206017, 00223549;0.944;Q1;186;204;631;6333;1514;630;2.19;31.04;United States;Northern America;"John Wiley &amp; Sons Inc.";1961-2021;Pharmaceutical Science (Q1)
68;29682;Receptors and Channels;journal;10606823;0.944;Q1;42;21;71;906;121;71;1.28;43.14;United Kingdom;Western Europe;Taylor and Francis Ltd.;1993-2004;"Clinical Biochemistry (Q1); Endocrinology (Q1); Pharmacology (Q1); Cell Biology (Q2)"
69;21333;European Journal of Pharmacology;journal;00142999, 18790712;0.94;Q1;189;798;2837;28458;6759;2832;2.3;35.66;Netherlands;Western Europe;Elsevier;1967-2021;Pharmacology (Q1)
70;22477;Investigational New Drugs;journal;01676997, 15730646;0.933;Q1;90;42;124;1353;371;122;4.03;32.21;Netherlands;Western Europe;Kluwer Academic Publishers;1983-2021;"Oncology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
71;21790;Antiviral Therapy;journal;20402058, 13596535;0.924;Q1;89;41;164;2087;329;147;2.12;50.9;United Kingdom;Western Europe;International Medical Press Ltd;1996-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
72;29712;Clinical Therapeutics;journal;1879114X, 01492918;0.907;Q1;140;169;481;5085;1348;389;2.85;30.09;United States;Northern America;Elsevier Inc.;1977-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
73;110112;Journal of Immunotherapy;journal;15249557, 15374513;0.874;Q1;97;37;142;1157;353;135;2.3;31.27;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1991-2021;"Pharmacology (Q1); Cancer Research (Q2); Immunology (Q2); Immunology and Allergy (Q2)"
74;13845;Bulletin of Mathematical Biology;journal;00928240, 15229602;0.867;Q1;90;49;146;1422;211;146;1.39;29.02;United States;Northern America;Springer New York;1973-2021;"Agricultural and Biological Sciences (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Environmental Science (miscellaneous) (Q1); Pharmacology (Q1); Computational Theory and Mathematics (Q2); Immunology (Q2); Mathematics (miscellaneous) (Q2); Neuroscience (miscellaneous) (Q2)"
75;16948;Chirality;journal;1520636X, 08990042;0.846;Q1;80;125;342;1788;573;337;1.6;14.3;United States;Northern America;Wiley-Liss Inc.;1989-2021;"Drug Discovery (Q1); Pharmacology (Q1); Analytical Chemistry (Q2); Organic Chemistry (Q2); Spectroscopy (Q2); Catalysis (Q3)"
76;20049;Behavioural Pharmacology;journal;14735849, 09558810;0.838;Q1;83;68;230;2986;428;222;1.81;43.91;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1992-2021;"Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
77;18075;Neurotoxicology and Teratology;journal;08920362, 18729738;0.826;Q1;103;64;226;2622;453;225;2.13;40.97;United States;Northern America;Elsevier Inc.;1987-2021;"Toxicology (Q1); Developmental Neuroscience (Q2); Cellular and Molecular Neuroscience (Q3)"
78;21332;European Journal of Pharmaceutics and Biopharmaceutics;journal;18733441, 09396411;0.814;Q1;168;76;227;1926;379;224;1.77;25.34;Netherlands;Western Europe;Elsevier;1991-2021;"Biotechnology (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1)"
79;25788;Bioorganic and Medicinal Chemistry Letters;journal;14643405, 0960894X;0.809;Q1;154;722;2043;14402;3777;2042;1.85;19.95;United Kingdom;Western Europe;Elsevier Ltd.;1991-2021;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmaceutical Science (Q1); Biochemistry (Q2); Molecular Medicine (Q2); Organic Chemistry (Q2); Molecular Biology (Q3)"
80;25223;Toxicology and Industrial Health;journal;07482337, 14770393;0.806;Q1;62;35;152;1166;385;149;2.12;33.31;United Kingdom;Western Europe;SAGE Publications Ltd;1985-2021;"Health, Toxicology and Mutagenesis (Q1); Public Health, Environmental and Occupational Health (Q1); Toxicology (Q1)"
81;22981;Journal of Cardiovascular Pharmacology;journal;15334023, 01602446;0.797;Q1;104;207;1180;6444;2240;1173;1.75;31.13;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1979-2021;"Cardiology and Cardiovascular Medicine (Q1); Pharmacology (Q1)"
82;37409;Anti-Cancer Drug Design;journal;02669536;0.795;Q1;53;33;161;1011;430;158;2.78;30.64;United States;Northern America;Cognizant Communication Corporation;1985-2001;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Drug Discovery (Q1); Oncology (Q1); Pharmacology (Q1); Biochemistry (Q2); Organic Chemistry (Q2)"
83;15840;Journal of Antibiotics;journal;00218820, 18811469;0.782;Q1;84;150;542;2187;648;464;1.18;14.58;United Kingdom;Western Europe;Japan Antibiotics Research Association;1953-2021;"Drug Discovery (Q1); Pharmacology (Q1)"
84;23453;Combinatorial Chemistry and High Throughput Screening;journal;13862073, 18755402;0.78;Q1;66;60;94;3583;260;89;2.49;59.72;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1998-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Computer Science Applications (Q2); Organic Chemistry (Q2)"
85;22769;Chemical and Pharmaceutical Bulletin;journal;00092363, 13475223;0.776;Q1;95;345;1160;6812;1371;1160;1.18;19.74;Japan;Asiatic Region;Pharmaceutical Society of Japan;1958-2021;"Chemistry (miscellaneous) (Q1); Drug Discovery (Q1); Medicine (miscellaneous) (Q1)"
86;19700180810;Alkaloids: Chemical and Biological Perspectives;book series;07358210;0.774;Q2;14;6;20;359;17;1;0.91;59.83;Netherlands;Western Europe;Elsevier;1996, 1998-1999, 2001;"Drug Discovery (Q2); Organic Chemistry (Q2)"
87;23061;Journal of Pharmaceutical and Biomedical Analysis;journal;07317085, 1873264X;0.774;Q1;133;317;956;6069;1166;952;1.18;19.15;Netherlands;Western Europe;Elsevier;1983-2022;"Clinical Biochemistry (Q1); Pharmaceutical Science (Q1); Analytical Chemistry (Q2); Drug Discovery (Q2); Spectroscopy (Q2)"
88;24763;Addictive Behaviors;journal;03064603;0.773;Q1;135;77;284;2233;461;282;1.24;29;United Kingdom;Western Europe;Elsevier Ltd.;1975-2022;"Clinical Psychology (Q1); Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
89;25786;Bioorganic and Medicinal Chemistry;journal;14643391, 09680896;0.771;Q1;171;348;831;11201;1512;830;1.84;32.19;United Kingdom;Western Europe;Elsevier Ltd.;1993-2021;"Clinical Biochemistry (Q1); Pharmaceutical Science (Q1); Biochemistry (Q2); Drug Discovery (Q2); Molecular Medicine (Q2); Organic Chemistry (Q2); Molecular Biology (Q3)"
90;21197;Pharmacology Biochemistry and Behavior;journal;00913057, 18735177;0.761;Q1;139;243;936;10486;1721;931;1.74;43.15;United States;Northern America;Elsevier Inc.;1973-2021;"Clinical Biochemistry (Q1); Pharmacology (Q1); Toxicology (Q1); Biochemistry (Q2); Behavioral Neuroscience (Q3); Biological Psychiatry (Q3)"
91;4900153304;Archives of Environmental and Occupational Health;journal;19338244;0.76;Q1;64;77;206;2192;319;194;1.37;28.47;United States;Northern America;Heldref Publications;2005-2021;"Environmental Science (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q1); Public Health, Environmental and Occupational Health (Q1); Toxicology (Q1)"
92;19900193739;Nucleic Acid Therapeutics;journal;21593345, 21593337;0.753;Q2;70;43;178;1466;376;173;1.87;34.09;United States;Northern America;Mary Ann Liebert Inc.;2011-2021;"Biochemistry (Q2); Drug Discovery (Q2); Molecular Medicine (Q2); Genetics (Q3); Molecular Biology (Q3)"
93;22454;International Journal of Pharmaceutics;journal;18733476, 03785173;0.74;Q1;229;369;1169;8782;1796;1154;1.58;23.8;Netherlands;Western Europe;Elsevier;1978-2021;Pharmaceutical Science (Q1)
94;4000150314;Chemical Biology and Drug Design;journal;17470277;0.736;-;82;115;357;3881;562;348;1.53;33.75;United Kingdom;Western Europe;Blackwell;2006-2021;"Biochemistry (Q2); Molecular Medicine (Q3)"
95;21165;PharmacoEconomics;journal;11707690, 11792027;0.732;Q1;104;108;399;4797;854;377;2.14;44.42;United Kingdom;Western Europe;Adis International Ltd;1992-2021;"Health Policy (Q1); Pharmacology (Q1); Public Health, Environmental and Occupational Health (Q1)"
96;12611;Drug Resistance Updates;journal;13687646, 15322084;0.727;Q1;119;42;155;3286;324;146;1.77;78.24;United States;Northern America;Churchill Livingstone;1998-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Cancer Research (Q2); Infectious Diseases (Q2); Oncology (Q2)"
97;19617;Antiviral Research;journal;01663542, 18729096;0.725;Q1;134;68;195;2952;497;195;2.12;43.41;Netherlands;Western Europe;Elsevier;1959, 1981-2021;"Pharmacology (Q1); Virology (Q2)"
98;20602;Clinical Neuropharmacology;journal;1537162X, 03625664;0.721;Q1;80;64;188;1886;392;181;1.7;29.47;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1982-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Neurology (clinical) (Q2)"
99;21326;European Journal of Clinical Pharmacology;journal;00316970, 14321041;0.72;Q1;114;181;467;3629;955;432;2.03;20.05;Germany;Western Europe;Springer Verlag;1968-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
100;22983;Journal of Clinical Pharmacology;journal;15524604, 00912700;0.718;Q1;121;171;491;4733;1036;476;2.26;27.68;United States;Northern America;Wiley-Blackwell;1973-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
101;29097;Cancer Chemotherapy and Pharmacology;journal;14320843, 03445704;0.713;Q1;114;174;447;4984;1005;444;2.22;28.64;Germany;Western Europe;Springer Verlag;1978-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1); Cancer Research (Q2); Oncology (Q2)"
102;24652;Chemico-Biological Interactions;journal;00092797;0.711;Q1;128;287;384;6587;793;381;1.76;22.95;Ireland;Western Europe;Elsevier Ireland Ltd;1969-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
103;15462;Biotechnology and Applied Biochemistry;journal;14708744, 08854513;0.709;Q2;74;58;201;1448;316;195;1.4;24.97;United States;Northern America;Wiley-Blackwell;1986-2021;"Medicine (miscellaneous) (Q1); Process Chemistry and Technology (Q1); Applied Microbiology and Biotechnology (Q2); Bioengineering (Q2); Biomedical Engineering (Q2); Biotechnology (Q2); Drug Discovery (Q2); Molecular Medicine (Q3)"
104;20473;Life Sciences;journal;18790631, 00243205;0.705;Q1;174;573;1897;18059;3749;1892;1.82;31.52;United States;Northern America;Elsevier Inc.;1962-2021;"Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2)"
105;22980;Journal of Basic and Clinical Physiology and Pharmacology;journal;21910286, 07926855;0.694;Q1;36;24;82;715;87;80;0.29;29.79;Germany;Western Europe;Walter de Gruyter GmbH;1985-1988, 1990-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Drug Discovery (Q2); Physiology (Q2)"
106;25214;Toxicologic Pathology;journal;15331601, 01926233;0.691;Q1;112;113;338;3607;633;313;1.63;31.92;United States;Northern America;SAGE Publications Inc.;1972-2021;"Pathology and Forensic Medicine (Q1); Toxicology (Q1); Cell Biology (Q3); Molecular Biology (Q3)"
107;21331;European Journal of Pharmaceutical Sciences;journal;18790720, 09280987;0.688;Q1;144;130;272;4008;522;261;1.95;30.83;Netherlands;Western Europe;Elsevier;1993-2021;Pharmaceutical Science (Q1)
108;86329;Mutation Research - Mutation Research Genomics;journal;13835726, 18731341;0.686;Q1;20;14;26;352;44;26;2.29;25.14;Netherlands;Western Europe;Elsevier BV;1997-2001;"Toxicology (Q1); Genetics (Q3)"
109;23412;Journal of AOAC International;journal;10603271;0.684;Q1;90;263;518;4980;675;517;1.33;18.94;United States;Northern America;AOAC International;1993-2021;"Agronomy and Crop Science (Q1); Food Science (Q1); Pharmacology (Q1); Analytical Chemistry (Q2); Environmental Chemistry (Q2)"
110;20580;Journal of Food Biochemistry;journal;17454514, 01458884;0.681;Q1;50;36;102;1014;84;102;0.6;28.17;United States;Northern America;Wiley-Blackwell;1977-2021;"Food Science (Q1); Pharmacology (Q1); Biophysics (Q2); Cell Biology (Q3)"
111;18073;NeuroToxicology;journal;18729711, 0161813X;0.677;Q2;122;80;287;3079;522;284;1.73;38.49;Netherlands;Western Europe;Elsevier;1979-2021;"Neuroscience (miscellaneous) (Q2); Toxicology (Q2)"
112;23050;Journal of Microencapsulation;journal;02652048, 14645246;0.674;Q1;81;72;189;1330;247;186;1.17;18.47;United Kingdom;Western Europe;Informa Healthcare;1984-2021;"Pharmaceutical Science (Q1); Bioengineering (Q2); Colloid and Surface Chemistry (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2)"
113;33577;Polymer Gels and Networks;journal;09667822;0.671;Q1;29;0;43;0;45;43;0;0;United Kingdom;Western Europe;Pergamon Press Ltd.;1993-1998;"Chemical Engineering (miscellaneous) (Q1); Pharmaceutical Science (Q1); Polymers and Plastics (Q1)"
114;22299;Therapeutic Drug Monitoring;journal;15363694, 01634356;0.67;Q1;96;109;361;2918;775;349;2.13;26.77;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1979-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
115;68602;Immunopharmacology;journal;01623109;0.666;Q1;68;0;338;0;712;331;2.16;0;Netherlands;Western Europe;Elsevier BV;1978-2000;Pharmacology (Q1)
116;23014;Journal of Drug Targeting;journal;10292330, 1061186X;0.663;Q1;95;40;164;1489;354;154;2.16;37.23;United Kingdom;Western Europe;Informa Healthcare;1986-1987, 1992-2021;Pharmaceutical Science (Q1)
117;25109;Inhalation Toxicology;journal;08958378, 10917691;0.659;Q2;90;75;297;2341;303;289;1.02;31.21;United Kingdom;Western Europe;Informa Healthcare;1989-2021;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q2)"
118;29550;Journal of Biochemical and Molecular Toxicology;journal;10956670, 10990461;0.659;Q2;62;41;129;1546;231;129;1.92;37.71;United States;Northern America;"John Wiley &amp; Sons Inc.";1998-2021;"Medicine (miscellaneous) (Q1); Biochemistry (Q2); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Molecular Biology (Q3); Molecular Medicine (Q3)"
119;23382;Clinical and Experimental Pharmacology and Physiology;journal;14401681, 03051870;0.656;Q1;107;204;593;6730;1009;591;1.6;32.99;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1974-2021;"Pharmacology (Q1); Physiology (Q2); Physiology (medical) (Q2)"
120;25151;Journal of Toxicology and Environmental Health - Part A: Current Issues;journal;10872620, 15287394;0.653;Q2;92;133;390;4550;587;386;1.3;34.21;United Kingdom;Western Europe;Taylor and Francis Ltd.;1996-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
121;22410;Inflammation Research;journal;1420908X, 10233830;0.641;Q1;94;153;447;4017;712;435;1.36;26.25;Switzerland;Western Europe;Birkhauser Verlag Basel;1995-2021;"Pharmacology (Q1); Immunology (Q3)"
122;15576;European Neuropsychopharmacology;journal;0924977X, 18737862;0.64;Q2;118;72;236;2827;446;215;1.86;39.26;Netherlands;Western Europe;Elsevier;1990-2021;"Pharmacology (medical) (Q1); Neurology (Q2); Neurology (clinical) (Q2); Pharmacology (Q2); Psychiatry and Mental Health (Q2); Biological Psychiatry (Q3)"
123;21196;Drug Discovery Today;journal;18785832, 13596446;0.638;Q2;185;362;372;5948;765;336;2.12;16.43;United Kingdom;Western Europe;Elsevier Ltd.;1996-2021;"Drug Discovery (Q2); Pharmacology (Q2)"
124;23363;Canadian Journal of Physiology and Pharmacology;journal;00084212, 12057541;0.633;Q2;87;138;403;5452;635;401;1.29;39.51;Canada;Northern America;National Research Council of Canada;1964-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Physiology (Q2); Physiology (medical) (Q2)"
125;25240;Toxicology Letters;journal;03784274, 18793169;0.625;Q2;150;185;731;6279;1290;724;1.64;33.94;Netherlands;Western Europe;Elsevier BV;1977-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
126;23015;Journal of Ethnopharmacology;journal;03788741, 18727573;0.622;Q2;205;195;591;4750;655;590;1;24.36;Ireland;Western Europe;Elsevier Ireland Ltd;1979-2022;"Drug Discovery (Q2); Pharmacology (Q2)"
127;22456;International Journal of Pharmacy Practice;journal;09617671, 20427174;0.617;Q1;39;40;108;888;101;103;0.86;22.2;United Kingdom;Western Europe;Oxford University Press;1991-2021;"Health Policy (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Pharmacy (Q1); Public Health, Environmental and Occupational Health (Q1)"
128;21167;Pharmacogenomics;journal;14622416, 17448042;0.616;Q2;94;40;35;2061;66;35;1.89;51.53;United Kingdom;Western Europe;Future Medicine Ltd.;2000-2021;"Pharmacology (Q2); Genetics (Q3); Molecular Medicine (Q3)"
129;110174;Prostaglandins and Other Lipid Mediators;journal;10988823;0.616;Q2;76;54;176;2140;268;172;1.74;39.63;United States;Northern America;Elsevier Inc.;1996, 1998-2021;"Pharmacology (Q2); Physiology (Q2); Biochemistry (Q3); Cell Biology (Q3)"
130;25864;Heterocycles;journal;03855414;0.611;Q2;66;334;1238;7775;1312;1229;1.1;23.28;Japan;Asiatic Region;Japan Institute of Heterocyclic Chemistry;1983-2021;"Analytical Chemistry (Q2); Organic Chemistry (Q2); Pharmacology (Q2)"
131;14805;Steroids;journal;0039128X, 18785867;0.608;Q2;107;105;322;3605;717;322;2.32;34.33;United States;Northern America;Elsevier Inc.;1963-2021;"Clinical Biochemistry (Q2); Endocrinology (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Biochemistry (Q3); Molecular Biology (Q3)"
132;21841;Food Additives and Contaminants;journal;0265203X, 14645122;0.603;Q2;102;124;309;2794;356;306;0.98;22.53;United Kingdom;Western Europe;Taylor and Francis Ltd.;1984-2008;"Food Science (Q1); Public Health, Environmental and Occupational Health (Q1); Chemistry (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
133;25176;Regulatory Toxicology and Pharmacology;journal;02732300, 10960295;0.597;Q2;112;63;233;3056;368;216;1.66;48.51;United States;Northern America;Academic Press Inc.;1970, 1981-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
134;16117;Pharmaceutical Biotechnology;journal;10780467;0.595;Q1;27;0;41;0;73;41;2.47;0;United States;Northern America;Kluwer/Plenum Publishers;1993, 1995-1999, 2002;"Pharmaceutical Science (Q1); Applied Microbiology and Biotechnology (Q2)"
135;24786;Alcohol and Alcoholism;journal;07350414, 14643502;0.586;Q2;103;89;296;3121;503;269;1.64;35.07;United Kingdom;Western Europe;Oxford University Press;1965-2021;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q2); Toxicology (Q2)"
136;18966;Mutagenesis;journal;02678357, 14643804;0.584;Q2;95;83;273;3246;450;271;1.58;39.11;United Kingdom;Western Europe;Oxford University Press;1986-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Genetics (Q3); Genetics (clinical) (Q3)"
137;25096;Food and Chemical Toxicology;journal;18736351, 02786915;0.573;Q2;183;136;402;5396;656;391;1.59;39.68;United Kingdom;Western Europe;Elsevier Ltd.;1982-2021;"Medicine (miscellaneous) (Q1); Food Science (Q2); Toxicology (Q2)"
138;23942;Biomedical Chromatography;journal;10990801, 02693879;0.571;Q2;68;79;310;2031;317;309;1;25.71;United Kingdom;Western Europe;John Wiley and Sons Ltd;1986-2021;"Medicine (miscellaneous) (Q1); Analytical Chemistry (Q2); Clinical Biochemistry (Q2); Drug Discovery (Q2); Pharmacology (Q2); Biochemistry (Q3); Molecular Biology (Q3)"
139;25898;Journal of Peptide Science;journal;10752617, 10991387;0.571;Q2;68;66;166;2222;233;162;1.48;33.67;United Kingdom;Western Europe;John Wiley and Sons Ltd;1995-2021;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Pharmacology (Q2); Biochemistry (Q3); Molecular Biology (Q3); Molecular Medicine (Q3); Organic Chemistry (Q3); Structural Biology (Q3)"
140;24785;Alcohol;journal;07418329;0.57;Q2;83;75;285;2747;406;279;1.29;36.63;United States;Northern America;Elsevier Inc.;1984-2021;"Health (social science) (Q1); Medicine (miscellaneous) (Q1); Neurology (Q2); Toxicology (Q2); Behavioral Neuroscience (Q3); Biochemistry (Q3)"
141;24604;Archives of Toxicology;journal;14320738, 03405761;0.569;Q2;121;102;284;3543;473;283;1.69;34.74;Germany;Western Europe;Springer Verlag;1930-1940, 1943-1944, 1972-2021;"Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
142;25219;Toxicology;journal;0300483X, 18793185;0.565;Q2;165;240;503;8747;873;493;1.71;36.45;Ireland;Western Europe;Elsevier Ireland Ltd;1959, 1973-2021;Toxicology (Q2)
143;25093;Environmental Toxicology;journal;15227278, 15204081;0.564;Q2;81;74;165;2271;178;161;1.09;30.69;United States;Northern America;"John Wiley &amp; Sons Inc.";1980, 1999-2021;"Management, Monitoring, Policy and Law (Q1); Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
144;20677;Current Opinion in Drug Discovery and Development;journal;13676733;0.561;Q2;81;82;160;3724;306;152;1.83;45.41;United Kingdom;Western Europe;Current Drugs Ltd.;1998-2010;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Pharmacology (Q2)"
145;14822;Xenobiotica;journal;00498254, 13665928;0.557;Q2;82;63;275;2378;559;274;1.94;37.75;United Kingdom;Western Europe;Informa Healthcare;1971-2021;"Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Pharmacology (Q2); Toxicology (Q2); Biochemistry (Q3)"
146;14487;Journal of Ocular Pharmacology and Therapeutics;journal;15577732, 10807683;0.553;Q2;64;59;175;1568;218;174;1.34;26.58;United States;Northern America;Mary Ann Liebert Inc.;1987, 1991-1993, 1995-2021;"Ophthalmology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
147;21767;Progress in Neuro-Psychopharmacology and Biological Psychiatry;journal;18784216, 02785846;0.552;Q2;134;102;291;5448;384;291;1.22;53.41;United States;Northern America;Elsevier Inc.;1982-2022;"Pharmacology (Q2); Biological Psychiatry (Q4)"
148;25075;Ecotoxicology;journal;09639292, 15733017;0.551;Q2;97;38;111;1374;113;106;0.86;36.16;Netherlands;Western Europe;Springer Netherlands;1992-2021;"Management, Monitoring, Policy and Law (Q1); Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
149;19888;Medical Letter on Drugs and Therapeutics;journal;0025732X, 15232859;0.55;Q2;20;62;167;0;171;167;1.23;0;United States;Northern America;Medical Letter Inc.;1965-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
150;25934;Cytokines, Cellular and Molecular Therapy;journal;14660830, 13684736;0.549;Q2;27;0;84;0;127;84;1.16;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;1997-2000, 2002;"Immunology and Allergy (Q2); Pharmacology (Q2); Immunology (Q3)"
151;21099;Pharmaceutical Development and Technology;journal;10837450, 10979867;0.548;Q1;62;63;214;1256;186;201;0.91;19.94;United States;Northern America;Informa Healthcare;1996-2021;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1)"
152;16803;Antiviral Chemistry and Chemotherapy;journal;20402066, 09563202;0.547;Q2;54;37;121;1504;220;121;1.91;40.65;United Kingdom;Western Europe;SAGE Publications Inc.;1991-2015, 2017-2021;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Pharmacology (Q2); Virology (Q3)"
153;34545;Journal of Asian Natural Products Research;journal;10286020, 14772213;0.542;Q1;42;47;83;416;53;83;0.6;8.85;United Kingdom;Western Europe;Taylor and Francis Ltd.;1998-2021;"Complementary and Alternative Medicine (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Drug Discovery (Q2); Pharmacology (Q2); Analytical Chemistry (Q3); Molecular Medicine (Q3); Organic Chemistry (Q3)"
154;16067;Reading Teacher;journal;00340561;0.54;Q2;53;62;188;1248;73;188;0.35;20.13;United States;Northern America;Wiley-Blackwell;1995-2021;"Linguistics and Language (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
155;24028;Reproductive Toxicology;journal;08906238, 18731708;0.532;Q2;117;64;205;2270;301;184;1.36;35.47;United States;Northern America;Elsevier Inc.;1987-2021;Toxicology (Q2)
156;9000153111;Comparative Biochemistry and Physiology Part - C: Toxicology and Pharmacology;journal;15320456, 18781659;0.528;Q2;113;133;368;5402;531;365;1.07;40.62;United States;Northern America;Elsevier Inc.;1989, 2000-2022;"Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Biochemistry (Q3); Cell Biology (Q3); Physiology (Q3)"
157;16533;Phytochemical Analysis;journal;09580344, 10991565;0.528;Q2;76;61;157;1210;162;157;0.89;19.84;United Kingdom;Western Europe;John Wiley and Sons Ltd;1990-2021;"Complementary and Alternative Medicine (Q1); Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Food Science (Q2); Plant Science (Q2); Analytical Chemistry (Q3); Biochemistry (Q3); Molecular Medicine (Q3)"
158;25095;Environmental Toxicology and Pharmacology;journal;13826689;0.526;Q2;88;42;131;1727;146;130;1.21;41.12;Netherlands;Western Europe;Elsevier;1996-2021;"Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Pharmacology (Q2); Toxicology (Q2)"
159;25789;Bioorganic Chemistry;journal;00452068, 10902120;0.522;Q2;66;33;104;1043;122;102;1.24;31.61;United States;Northern America;Academic Press Inc.;1971-2021;"Drug Discovery (Q2); Biochemistry (Q3); Molecular Biology (Q3); Organic Chemistry (Q3)"
160;21351;Expert Opinion on Investigational Drugs;journal;13543784, 17447658;0.521;Q2;109;357;580;22450;912;575;1.71;62.89;United Kingdom;Western Europe;Taylor and Francis Ltd.;1994-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
161;33349;Japanese Journal of Pharmacology;journal;13473506, 00215198;0.52;Q2;62;186;538;5544;668;538;1.26;29.81;Japan;Asiatic Region;Japanese Pharmacological Society;1951-2002;Pharmacology (Q2)
162;20634;Journal of Texture Studies;journal;00224901, 17454603;0.517;Q1;57;24;120;590;81;120;0.47;24.58;United States;Northern America;Wiley-Blackwell;1969-2021;"Pharmaceutical Science (Q1); Food Science (Q2)"
163;28727;Anti-Cancer Drugs;journal;09594973, 14735741;0.514;Q2;96;131;370;4095;643;369;1.65;31.26;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1990-2021;"Oncology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2); Cancer Research (Q3)"
164;55157;Perspectives in Drug Discovery and Design;journal;15739023, 09282866;0.508;Q2;38;0;95;0;171;91;1.64;0;Netherlands;Western Europe;Kluwer Academic Publishers;1993-2000;"Drug Discovery (Q2); Pharmacology (Q2); Organic Chemistry (Q3)"
165;28620;Biomedicine and Pharmacotherapy;journal;07533322;0.504;Q2;109;100;307;3078;343;276;1.02;30.78;France;Western Europe;Elsevier Masson s.r.l.;1982-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
166;21194;Pharmacology;journal;00317012, 14230313;0.5;Q2;60;72;219;2097;305;211;1.57;29.13;Switzerland;Western Europe;S. Karger AG;1959-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
167;17595;Journal of Biomolecular Screening;journal;10870571, 1552454X;0.497;Q2;79;42;128;885;231;112;2.13;21.07;United States;Northern America;SAGE Publications Inc.;1996-2017;"Biotechnology (Q2); Drug Discovery (Q2); Pharmacology (Q2); Analytical Chemistry (Q3); Biochemistry (Q3); Molecular Medicine (Q3)"
168;22319;Toxicon;journal;18793150, 00410101;0.494;Q2;133;228;492;7582;726;479;1.49;33.25;United Kingdom;Western Europe;Elsevier Ltd.;1962-2021;Toxicology (Q2)
169;28794;Cancer Biotherapy and Radiopharmaceuticals;journal;10849785, 15578852;0.492;Q2;63;58;170;1918;256;152;1.53;33.07;United States;Northern America;Mary Ann Liebert Inc.;1996-2021;"Medicine (miscellaneous) (Q1); Oncology (Q2); Pharmacology (Q2); Radiology, Nuclear Medicine and Imaging (Q2); Cancer Research (Q3)"
170;20570;Chemotherapy;journal;00093157, 14219794;0.492;Q2;58;98;223;2623;283;217;1.32;26.77;Switzerland;Western Europe;S. Karger AG;1960-2021;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Infectious Diseases (Q2); Oncology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
171;22452;International Journal of Neuropsychopharmacology;journal;14611457, 14695111;0.49;Q2;113;50;113;2485;150;110;1.34;49.7;United Kingdom;Western Europe;Oxford University Press;1998-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2); Psychiatry and Mental Health (Q2)"
172;24640;Journal of Liquid Chromatography and Related Technologies;journal;1520572X, 10826076;0.484;Q1;51;234;681;4179;569;678;0.8;17.86;United States;Northern America;Taylor and Francis Ltd.;1996-2021;"Pharmaceutical Science (Q1); Clinical Biochemistry (Q2); Analytical Chemistry (Q3); Biochemistry (Q3)"
173;23479;Journal of Physiology and Pharmacology;journal;08675910, 18991505;0.484;Q2;81;67;205;2471;360;204;1.77;36.88;Poland;Eastern Europe;Polish Physiological Society;1991-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Physiology (Q3)"
174;36497;Pharmaceutica Acta Helvetiae;journal;00316865;0.48;Q1;40;0;123;0;145;121;1.38;0;Netherlands;Western Europe;Elsevier BV;1945-2000;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Molecular Medicine (Q3)"
175;23035;Journal of Biopharmaceutical Statistics;journal;10543406, 15205711;0.479;Q2;52;25;121;549;72;118;0.58;21.96;United States;Northern America;Taylor and Francis Ltd.;1991-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2); Statistics and Probability (Q3)"
176;17464;European Journal of Medicinal Chemistry;journal;02235234, 17683254;0.477;Q2;175;87;314;2751;392;308;1.29;31.62;France;Western Europe;Elsevier Masson s.r.l.;1974-2021;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Pharmacology (Q2); Organic Chemistry (Q3)"
177;25126;Journal of Applied Toxicology;journal;10991263, 0260437X;0.459;Q2;91;124;235;3352;279;232;1.14;27.03;United Kingdom;Western Europe;John Wiley and Sons Ltd;1981-2021;Toxicology (Q2)
178;23081;Journal of Pharmacokinetics and Pharmacodynamics;journal;15738744, 1567567X;0.459;Q2;64;29;68;670;76;66;0.88;23.1;United States;Northern America;Springer New York;1996-1999, 2001-2021;Pharmacology (Q2)
179;81781;Pharmaceutical Science and Technology Today;journal;14615347;0.459;Q1;54;0;261;0;298;241;1.09;0;Netherlands;Western Europe;Elsevier BV;1998-2000;Pharmaceutical Science (Q1)
180;22378;Vascular Pharmacology;journal;18793649, 15371891;0.459;Q2;100;1;518;13;590;515;0.79;13;United States;Northern America;Elsevier Inc.;2002-2021;"Pharmacology (Q2); Molecular Medicine (Q3); Physiology (Q3)"
181;22552;Cardiovascular Drugs and Therapy;journal;15737241, 09203206;0.454;Q2;71;86;223;2630;226;194;0.98;30.58;Netherlands;Western Europe;Kluwer Academic Publishers;1987-2021;"Medicine (miscellaneous) (Q1); Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
182;25106;Human and Experimental Toxicology;journal;09603271;0.452;Q2;82;114;325;740;376;306;1.09;6.49;United States;Northern America;SAGE Publications Inc.;1981-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q2); Health, Toxicology and Mutagenesis (Q3)"
183;22434;International Journal of Clinical Pharmacology and Therapeutics;journal;09461965;0.452;Q2;69;90;289;1848;433;279;1.61;20.53;Germany;Western Europe;Dustri-Verlag Dr. Karl Feistle;1994-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
184;24624;Bulletin of Environmental Contamination and Toxicology;journal;00074861, 14320800;0.449;Q2;76;247;702;4053;455;701;0.51;16.41;United States;Northern America;Springer New York;1966-2021;"Medicine (miscellaneous) (Q1); Pollution (Q2); Toxicology (Q2); Health, Toxicology and Mutagenesis (Q3)"
185;21190;Drug Development and Industrial Pharmacy;journal;03639045, 15205762;0.449;Q2;90;129;506;2807;392;503;0.66;21.76;United States;Northern America;Informa Healthcare;1974, 1976-2021;"Drug Discovery (Q2); Pharmacology (Q2); Organic Chemistry (Q3)"
186;22372;Immunopharmacology and Immunotoxicology;journal;15322513, 08923973;0.449;Q2;53;53;137;1624;170;137;1.18;30.64;United Kingdom;Western Europe;Informa Healthcare;1978-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Toxicology (Q2); Immunology (Q3); Immunology and Allergy (Q3)"
187;22365;International Antiviral News;journal;09652310;0.448;Q2;8;25;84;313;63;54;1.02;12.52;United Kingdom;Western Europe;International Medical Press Ltd;1994-2001;"Pharmacology (Q2); Virology (Q3)"
188;18403;Apoptosis : an international journal on programmed cell death;journal;13608185, 1573675X;0.446;Q1;115;47;159;3353;143;159;0.89;71.34;Netherlands;Western Europe;Springer Netherlands;1996-2021;"Pharmaceutical Science (Q1); Biochemistry (medical) (Q2); Pharmacology (Q2); Cancer Research (Q3); Cell Biology (Q3); Clinical Biochemistry (Q3)"
189;20766;Drug and Chemical Toxicology;journal;01480545, 15256014;0.446;Q2;46;27;135;804;124;134;0.79;29.78;United States;Northern America;Informa Healthcare;1977-2021;"Chemical Health and Safety (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q2); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q2); Health, Toxicology and Mutagenesis (Q3)"
190;13671;Biologicals;journal;10958320, 10451056;0.439;Q2;60;38;140;776;144;135;0.8;20.42;United States;Northern America;Academic Press Inc.;1990-2021;"Medicine (miscellaneous) (Q1); Biotechnology (Q2); Pharmacology (Q2); Applied Microbiology and Biotechnology (Q3); Bioengineering (Q3); Immunology and Microbiology (miscellaneous)  (Q3)"
191;21169;Pharmacological Research;journal;10436618, 10961186;0.437;Q2;147;151;462;6429;568;461;1.27;42.58;United States;Northern America;Academic Press Inc.;1989-2021;Pharmacology (Q2)
192;24626;Cell Biology and Toxicology;journal;15736822, 07422091;0.433;Q3;64;33;122;1383;165;121;1.18;41.91;Netherlands;Western Europe;Springer Netherlands;1984-2021;"Cell Biology (Q3); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
193;27210;In Vivo;journal;17917549, 0258851X;0.433;Q2;64;84;298;2416;332;296;1.08;28.76;Greece;Western Europe;International Institute of Anticancer Research;1987-2021;"Medicine (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Pharmacology (Q2)"
194;20545;PDA Journal of Pharmaceutical Science and Technology;journal;19482124, 10797440;0.432;Q1;40;47;174;958;93;125;0.46;20.38;United States;Northern America;Parenteral Drug Association Inc.;1994-2021;Pharmaceutical Science (Q1)
195;11700154735;Journal of Aerosol Medicine and Pulmonary Drug Delivery;journal;19412703, 19412711;0.43;Q1;73;57;118;1297;171;113;1.15;22.75;United States;Northern America;Mary Ann Liebert Inc.;2008-2021;"Pharmaceutical Science (Q1); Pharmacology (medical) (Q2); Pulmonary and Respiratory Medicine (Q2)"
196;19956;Archiv der Pharmazie;journal;15214184, 03656233;0.429;Q2;65;70;210;1384;202;207;0.99;19.77;Germany;Western Europe;Wiley-VCH Verlag;1822-1831, 1835-1933, 1937-1938, 1940, 1943-1944, 1950-2021;"Pharmaceutical Science (Q2); Drug Discovery (Q3)"
197;23007;Journal of Clinical Pharmacy and Therapeutics;journal;13652710, 02694727;0.429;Q2;76;63;186;1888;244;169;1.38;29.97;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1976-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
198;29947;Journal of Chemotherapy;journal;1120009X, 19739478;0.428;Q2;52;150;295;4474;372;283;1.32;29.83;United Kingdom;Western Europe;Maney Publishing;1989-2021;"Medicine (miscellaneous) (Q1); Oncology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2); Infectious Diseases (Q3)"
199;23129;Journal of Veterinary Pharmacology and Therapeutics;journal;01407783, 13652885;0.423;Q2;62;70;187;1684;139;186;0.77;24.06;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1978-2021;"Pharmacology (Q2); Veterinary (miscellaneous) (Q2)"
200;18384;Medicinal Chemistry Research;journal;10542523, 15548120;0.421;Q1;50;27;121;751;128;118;0.83;27.81;United States;Northern America;Birkhauser Boston;1994, 1996-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Organic Chemistry (Q3)"
201;22982;Journal of Cardiovascular Pharmacology and Therapeutics;journal;10742484, 19404034;0.416;Q2;52;43;110;1572;89;102;0.94;36.56;United Kingdom;Western Europe;SAGE Publications Ltd;1996-2021;"Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
202;17605;Journal of Enzyme Inhibition and Medicinal Chemistry;journal;14756374, 14756366;0.414;Q2;79;52;112;1639;150;112;1.23;31.52;United Kingdom;Western Europe;Informa Healthcare;1985-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Drug Discovery (Q3)"
203;19443;American Journal of Health-System Pharmacy;journal;10792082, 15352900;0.411;Q2;99;411;1396;3687;935;796;0.72;8.97;United States;Northern America;American Society of Health-Systems Pharmacy;1995-2021;"Health Policy (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
204;68818;International Journal of Geriatric Psychopharmacology;journal;13648233;0.411;Q1;11;0;75;0;102;71;0.41;0;United Kingdom;Western Europe;Stockton Press;1997-2000;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Geriatrics and Gerontology (Q2); Pharmacology (medical) (Q2); Neuropsychology and Physiological Psychology (Q3)"
205;17067;Phytomedicine;journal;09447113, 1618095X;0.409;Q2;127;73;199;1998;235;196;1.2;27.37;Germany;Western Europe;Urban und Fischer Verlag Jena;1994-2021;"Complementary and Alternative Medicine (Q1); Pharmaceutical Science (Q2); Pharmacology (Q2); Drug Discovery (Q3); Molecular Medicine (Q3)"
206;20680;Current Opinion in Molecular Therapeutics;journal;14648431;0.405;Q2;66;82;183;3634;214;170;1.17;44.32;United Kingdom;Western Europe;Current Drugs Ltd.;1999-2010;"Pharmacology (Q2); Drug Discovery (Q3); Genetics (clinical) (Q3); Molecular Medicine (Q3); Genetics (Q4); Molecular Biology (Q4)"
207;21353;Expert Opinion on Therapeutic Patents;journal;13543776, 17447674;0.404;Q2;77;126;429;6674;437;424;1.02;52.97;United Kingdom;Western Europe;Taylor and Francis Ltd.;1991-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Drug Discovery (Q3)"
208;23489;Chemical Speciation and Bioavailability;journal;09542299;0.4;Q3;0;0;0;0;0;0;0;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;1989-2018;"Chemical Health and Safety (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
209;20064;Biological and Pharmaceutical Bulletin;journal;13475215, 09186158;0.395;Q2;122;311;921;8021;894;921;0.9;25.79;Japan;Asiatic Region;Pharmaceutical Society of Japan;1993-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (Q2)"
210;21192;Drug Development Research;journal;02724391, 10982299;0.391;Q3;62;130;282;1096;320;276;1.05;8.43;United States;Northern America;"John Wiley &amp; Sons Inc.";1981-2021;Drug Discovery (Q3)
211;23039;Journal of Liposome Research;journal;08982104, 15322394;0.39;Q2;53;28;107;1003;110;88;1.01;35.82;United Kingdom;Western Europe;Informa Healthcare;1988-1990, 1992-2021;Pharmaceutical Science (Q2)
212;34645;Skin Pharmacology and Physiology;journal;16605527, 16605535;0.388;Q2;78;58;129;1905;169;127;1.28;32.84;Switzerland;Western Europe;S. Karger AG;1988-1997, 2004-2021;"Dermatology (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Physiology (Q3)"
213;20047;Basic and Clinical Pharmacology and Toxicology;journal;17427843, 17427835;0.384;Q2;93;111;308;1537;339;302;0.94;13.85;United States;Northern America;Wiley-Blackwell;2004-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Toxicology (Q3)"
214;24071;Metal-Based Drugs;journal;07930291, 16875486;0.383;Q2;38;48;134;1542;120;133;0.9;32.13;United States;Northern America;Hindawi Publishing Corporation;1996-2002, 2007-2011;"Pharmacology (Q2); Drug Discovery (Q3); Inorganic Chemistry (Q3); Toxicology (Q3)"
215;16573;Phytotherapy Research;journal;10991573, 0951418X;0.382;Q2;140;150;491;3332;357;489;0.78;22.21;United Kingdom;Western Europe;John Wiley and Sons Ltd;1987-2021;Pharmacology (Q2)
216;21865;Fundamental and Clinical Pharmacology;journal;07673981, 14728206;0.379;Q2;77;52;219;1599;260;215;1.08;30.75;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1987-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
217;37697;Autonomic and Autacoid Pharmacology;journal;14748673, 14748665;0.376;Q2;21;0;0;0;0;0;0;0;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2002-2017;Pharmacology (Q2)
218;25305;SAR and QSAR in Environmental Research;journal;1029046X, 1062936X;0.376;Q3;50;45;49;66;83;49;1.94;1.47;United Kingdom;Western Europe;Taylor and Francis Ltd.;1993-2021;"Medicine (miscellaneous) (Q2); Bioengineering (Q3); Drug Discovery (Q3); Molecular Medicine (Q3)"
219;19958;Archives of Pharmacal Research;journal;19763786, 02536269;0.373;Q3;93;105;363;2196;287;363;0.78;20.91;South Korea;Asiatic Region;Pharmaceutical Society of Korea;1978-2021;"Drug Discovery (Q3); Molecular Medicine (Q3); Organic Chemistry (Q3)"
220;28675;Brazilian Journal of Medical and Biological Research;journal;0100879X, 1414431X;0.373;Q2;91;202;595;5977;532;594;0.89;29.59;Brazil;Latin America;Associacao Brasileira de Divulgacao Cientifica;1973-2021;"Medicine (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry (Q3); Biophysics (Q3); Immunology (Q3); Neuroscience (miscellaneous) (Q3); Physiology (Q3); Cell Biology (Q4)"
221;4000148406;Clinical Toxicology;journal;15569519, 15563650;0.369;Q3;98;88;323;1775;457;249;1.62;20.17;United Kingdom;Western Europe;Informa Healthcare;1968-1998, 2005-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q3)"
222;26766;ATLA Alternatives to Laboratory Animals;journal;02611929;0.367;Q3;61;65;188;1402;178;163;0.78;21.57;United Kingdom;Western Europe;FRAME;1982, 1985-1986, 1988-1989, 1994-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medical Laboratory Technology (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q3)"
223;19900192900;Molecular Informatics;journal;18681751, 18681743;0.365;Q3;70;29;92;865;104;90;1.21;29.83;Germany;Western Europe;"Wiley - VCH Verlag GmbH &amp; CO. KGaA";2010-2021;"Computer Science Applications (Q3); Drug Discovery (Q3); Organic Chemistry (Q3); Molecular Medicine (Q4); Structural Biology (Q4)"
224;21265;Drugs of the Future;journal;03778282;0.363;Q2;45;84;315;4137;311;315;1.09;49.25;Spain;Western Europe;Prous Science;1978-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
225;22204;Journal of Drug Delivery Science and Technology;journal;17732247, 25888943;0.358;Q2;52;61;193;1945;133;193;0.6;31.89;France;Western Europe;Editions de Sante;2004-2021;Pharmaceutical Science (Q2)
226;19700185200;Journal of Natural Medicines;journal;13403443, 18610293;0.357;Q2;50;72;263;887;96;253;0.32;12.32;Germany;Western Europe;Springer Verlag;2006-2021;"Complementary and Alternative Medicine (Q1); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Drug Discovery (Q3); Organic Chemistry (Q3)"
227;80381;Tumor Targeting;journal;13518488;0.357;Q2;10;0;54;0;62;52;1.44;0;United Kingdom;Western Europe;Stockton Press;1998-1999;"Pharmacology (Q2); Cancer Research (Q3)"
228;21186;Drug Design and Discovery;journal;10559612, 10292322;0.35;Q3;20;1;66;0;53;62;0.8;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;1991-2003;"Drug Discovery (Q3); Molecular Medicine (Q4)"
229;19700182275;International Journal of Clinical Pharmacy;journal;22107711, 22107703;0.35;Q2;63;60;130;941;105;125;0.73;15.68;Netherlands;Western Europe;Springer Netherlands;2011-2021;"Pharmacy (Q1); Pharmaceutical Science (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2); Toxicology (Q3)"
230;25129;Journal of Environmental Pathology, Toxicology and Oncology;journal;07318898;0.35;Q3;47;54;132;1834;112;130;0.83;33.96;United States;Northern America;Begell House Inc.;1984-1990, 1992-2021;"Medicine (miscellaneous) (Q2); Pathology and Forensic Medicine (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
231;130089;Toxin Reviews;journal;15569543, 15569551;0.348;Q3;46;15;90;859;63;87;0.81;57.27;United Kingdom;Western Europe;Informa Healthcare;1982-2021;Toxicology (Q3)
232;19700180785;Studies in Natural Products Chemistry;book series;15725995;0.337;Q3;41;24;76;3908;36;33;0.47;162.83;Netherlands;Western Europe;Elsevier;1995-1997, 2000-2003, 2005-2006, 2008, 2012-2021;"Drug Discovery (Q3); Organic Chemistry (Q3)"
233;110097;Food and Drug Law Journal;journal;1064590X;0.336;Q2;22;25;140;1303;47;140;0.22;52.12;United States;Northern America;Food and Drug Law Institute;1992-2018, 2021;"Law (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Public Health, Environmental and Occupational Health (Q2)"
234;21100829249;Biotherapy;journal;15738280, 0921299X;0.335;Q2;21;0;49;0;59;48;0;0;Switzerland;Western Europe;Springer International Publishing AG;1988-1994, 1996-1998;Pharmacology (Q2)
235;25224;Toxicology in Vitro;journal;18793177, 08872333;0.332;Q3;112;96;245;2613;242;244;0.93;27.22;United Kingdom;Western Europe;Elsevier Ltd.;1987-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q3)"
236;12000154522;Advances in Antiviral Drug Design;book series;10758593;0.33;Q2;12;0;7;0;7;5;1;0;United Kingdom;Western Europe;Elsevier Ltd.;1996, 1999, 2003, 2007;"Pharmacology (medical) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Infectious Diseases (Q3); Virology (Q4)"
237;20663;Current Drug Metabolism;journal;18755453, 13892002;0.329;Q2;111;28;20;2547;16;20;0.8;90.96;Netherlands;Western Europe;Bentham Science Publishers B.V.;2000-2021;"Pharmacology (Q2); Clinical Biochemistry (Q3)"
238;24111;Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry;journal;03764699, 09750983;0.329;Q2;48;272;697;5087;325;696;0.44;18.7;India;Asiatic Region;Scientific Publishers of India;1970, 1973-1978, 1981, 1989-1991, 1996-2018, 2020-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Organic Chemistry (Q3)"
239;25189;Reviews in Toxicology;journal;13826980;0.329;Q3;20;5;44;603;37;43;0.38;120.6;Netherlands;Western Europe;IOS Press BV;1997-1999, 2001;Toxicology (Q3)
240;36479;International Journal of Immunopharmacology;journal;01920561;0.325;Q3;50;0;273;0;323;266;1.14;0;Netherlands;Western Europe;Elsevier BV;1979-2000;"Pharmacology (Q3); Immunology (Q4)"
241;24043;Journal of Labelled Compounds and Radiopharmaceuticals;journal;03624803, 10991344;0.323;Q3;48;100;704;1831;369;702;0.51;18.31;United Kingdom;Western Europe;John Wiley and Sons Ltd;1976-2021;"Analytical Chemistry (Q3); Biochemistry (Q3); Drug Discovery (Q3); Organic Chemistry (Q3); Radiology, Nuclear Medicine and Imaging (Q3); Spectroscopy (Q3)"
242;21717;Die Pharmazie;journal;00317144;0.322;Q2;66;240;727;6001;416;724;0.57;25;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1947-2021;Pharmaceutical Science (Q2)
243;23055;Journal of Natural Toxins;journal;10588108;0.321;Q3;26;32;87;731;92;87;1.02;22.84;United States;Northern America;Alaken Inc.;1996-2002;"Environmental Science (miscellaneous) (Q2); Toxicology (Q3)"
244;21262;Drugs under Experimental and Clinical Research;journal;03786501;0.319;Q3;39;28;138;951;174;137;1.52;33.96;Switzerland;Western Europe;Bioscience Ediprint Inc.;1980-2005;"Pharmacology (medical) (Q2); Drug Discovery (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
245;24749;Addiction Biology;journal;13556215, 13691600;0.315;Q3;83;39;136;1371;97;134;0.59;35.15;United States;Northern America;Wiley-Blackwell;1996-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q3); Psychiatry and Mental Health (Q3)"
246;32946;Developments in Biological Standardization;journal;03015149;0.315;Q3;42;0;313;0;297;313;0.64;0;Switzerland;Western Europe;S. Karger AG;1974-2000;"Public Health, Environmental and Occupational Health (Q2); Biotechnology (Q3); Drug Discovery (Q3); Immunology and Microbiology (miscellaneous)  (Q3)"
247;73430;Pharmaceutical Technology;journal;15432521;0.315;Q2;38;104;325;1009;107;299;0.26;9.7;United States;Northern America;Advanstar Communications Inc.;1979-1985, 1987, 1996-2021;"Pharmaceutical Science (Q2); Biophysics (Q3)"
248;26568;International Journal of Cosmetic Science;journal;01425463, 14682494;0.314;Q2;66;42;116;838;82;113;0.67;19.95;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1979-2021;"Chemistry (miscellaneous) (Q2); Dermatology (Q2); Pharmaceutical Science (Q2); Aging (Q3); Colloid and Surface Chemistry (Q3); Drug Discovery (Q3)"
249;22375;Indian Drugs;journal;0019462X;0.311;Q2;31;149;432;2260;104;417;0.21;15.17;India;Asiatic Region;Indian Drug Manufacturers' Association;1989-2021;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Pharmacology (Q3)"
250;25146;Journal of Pharmacological and Toxicological Methods;journal;10568719;0.311;Q3;75;49;185;1674;168;183;0.67;34.16;United States;Northern America;Elsevier Inc.;1992-2002, 2004-2021;"Pharmacology (Q3); Toxicology (Q3)"
251;28636;Birth Defects Research Part B - Developmental and Reproductive Toxicology;journal;15429733, 15429741;0.307;Q3;52;0;0;0;0;0;0;0;United States;Northern America;Wiley-Liss Inc.;2003-2016;"Embryology (Q3); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3); Developmental Biology (Q4)"
252;18077;Fitoterapia;journal;0367326X, 18736971;0.305;Q3;110;193;466;2266;214;466;0.44;11.74;Netherlands;Western Europe;Elsevier;1948-1949, 1961, 1972-2021;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3); Pharmacology (Q3)"
253;21352;Expert Opinion on Pharmacotherapy;journal;17447666, 14656566;0.301;Q3;83;168;105;11843;122;104;1.16;70.49;United Kingdom;Western Europe;Taylor and Francis Ltd.;1999-2021;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
254;27087;American Journal of Therapeutics;journal;10752765, 15363686;0.3;Q3;63;58;171;330;125;151;0.76;5.69;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1960-1961, 1996-2021;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
255;20066;Biopharmaceutics and Drug Disposition;journal;1099081X, 01422782;0.299;Q2;61;36;183;1661;147;181;0.86;46.14;United Kingdom;Western Europe;John Wiley and Sons Ltd;1979-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
256;20129;Cardiovascular Drug Reviews;journal;15273466, 08975957;0.299;Q3;50;25;80;1597;59;80;0.52;63.88;United States;Northern America;Neva Press, Inc.;1983-2007;"Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q3)"
257;21082;Pharmaceutical Biology;journal;13880209, 17445116;0.297;Q2;72;97;232;2172;93;229;0.35;22.39;United Kingdom;Western Europe;Taylor and Francis Ltd.;1961-1972, 1975-2021;"Complementary and Alternative Medicine (Q1); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (Q3); Drug Discovery (Q4); Molecular Medicine (Q4)"
258;19403;Acta Pharmacologica Sinica;journal;16714083, 17457254;0.294;Q3;98;207;589;3661;357;588;0.67;17.69;United Kingdom;Western Europe;Nature Publishing Group;1980-2021;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
259;20770;Drug Delivery;journal;10717544, 15210464;0.29;Q2;72;29;97;902;62;97;0.71;31.1;United Kingdom;Western Europe;Informa Healthcare;1993, 1995-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
260;29053;Molecular Diversity;journal;1573501X, 13811991;0.29;Q4;58;0;51;0;52;50;0.15;0;Netherlands;Western Europe;Springer Netherlands;1995-1998, 2000, 2003-2021;"Medicine (miscellaneous) (Q2); Information Systems (Q3); Inorganic Chemistry (Q3); Physical and Theoretical Chemistry (Q3); Catalysis (Q4); Drug Discovery (Q4); Molecular Biology (Q4); Organic Chemistry (Q4)"
261;21412;Zeitschrift fur Phytotherapie : offizielles Organ der Ges. f. Phytotherapie e.V;journal;0722348X;0.289;Q3;13;47;137;593;31;105;0.15;12.62;Germany;Western Europe;Hippokrates Verlag GmbH;1982, 1985-2021;"Complementary and Alternative Medicine (Q2); Pharmacology (Q3)"
262;21100470510;Drug Research;journal;21949379, 21949387;0.288;Q4;65;136;569;3155;454;564;0.85;23.2;Germany;Western Europe;Thieme;1972, 2013-2021;"Medicine (miscellaneous) (Q2); Drug Discovery (Q4)"
263;19447;Journal of the American Pharmacists Association : JAPhA;journal;15443191, 15443450;0.286;Q3;67;110;340;950;271;319;0.83;8.64;United States;Northern America;American Pharmacists Association;2003-2021;"Pharmacy (Q1); Pharmacology (nursing) (Q2); Pharmacology (Q3)"
264;38865;Natural Toxins;journal;10569014;0.285;Q3;47;0;86;0;114;84;1.09;0;United States;Northern America;"John Wiley &amp; Sons Inc.";1992-1999;Toxicology (Q3)
265;52649;Pharmaceutical and Pharmacological Letters;journal;09399488;0.276;Q2;17;27;105;380;41;104;0.43;14.07;Germany;Western Europe;Stuttgart Medpharm Scientific Publishers;1996-2001;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
266;40278;Adverse Drug Reactions and Toxicological Reviews;journal;0964198X;0.275;Q3;24;21;54;738;52;28;0.93;35.14;United Kingdom;Western Europe;Adis International Ltd;1991-2002;"Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Toxicology (Q3)"
267;4400151608;ChemMedChem;journal;18607187, 18607179;0.273;Q2;106;157;351;2845;249;348;0.74;18.12;United Kingdom;Western Europe;John Wiley and Sons Ltd;2006-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Molecular Medicine (Q4); Organic Chemistry (Q4)"
268;20578;Journal of Food and Drug Analysis;journal;10219498;0.268;Q3;63;37;108;678;24;108;0.24;18.32;Taiwan;Asiatic Region;National Laboratories of Foods and Drugs;1994-2021;"Food Science (Q3); Pharmacology (Q3)"
269;23102;Journal of Pharmacy and Pharmacology;journal;20427158, 00223573;0.264;Q2;124;213;1438;6060;859;1408;0.57;28.45;United Kingdom;Western Europe;Oxford University Press;1949-2021;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
270;57765;Journal of Serotonin Research;journal;13507702;0.263;Q3;8;0;6;0;5;6;0;0;Netherlands;Western Europe;Koninklijke Nederlandse Maatschappij voor Diergeneeskunde;1994-1998;"Neuroscience (miscellaneous) (Q3); Pharmacology (Q3)"
271;13248;Experimental and Toxicologic Pathology;journal;09402993, 16181433;0.261;Q3;70;63;219;1858;157;216;0.66;29.49;Germany;Western Europe;Urban und Fischer Verlag Jena;1992-2017;"Medicine (miscellaneous) (Q2); Pathology and Forensic Medicine (Q3); Toxicology (Q3); Cell Biology (Q4)"
272;21825;Reviews in Contemporary Pharmacotherapy;journal;09548602;0.261;Q3;17;6;79;1445;106;79;2.25;240.83;United Kingdom;Western Europe;Marius Press;1996-2004;Pharmacology (Q3)
273;21229;Drug News and Perspectives;journal;02140934;0.26;Q3;51;60;174;2697;107;174;0.5;44.95;Spain;Western Europe;Prous Science;1990-2010;"Medicine (miscellaneous) (Q2); Pharmacology (Q3); Drug Discovery (Q4)"
274;24578;Mathematical Medicine and Biology;journal;14778599;0.26;Q3;46;19;64;472;38;64;0.41;24.84;United Kingdom;Western Europe;Oxford University Press;1984-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Environmental Science (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Applied Mathematics (Q3); Immunology and Microbiology (miscellaneous)  (Q3); Modeling and Simulation (Q3); Neuroscience (miscellaneous) (Q3); Pharmacology (Q3)"
275;25171;Mycotoxin Research;journal;18671632, 01787888;0.259;Q3;40;66;89;680;32;88;0.35;10.3;Germany;Western Europe;Springer-Verlag GmbH and Co. KG;1985-2021;"Biotechnology (Q3); Toxicology (Q3); Microbiology (Q4)"
276;17783;Research Communications in Molecular Pathology and Pharmacology;journal;10780297;0.259;Q3;39;61;297;1450;183;296;0.54;23.77;United States;Northern America;PJD Publications Ltd;1994-2007, 2009;"Medicine (miscellaneous) (Q2); Pharmacology (Q3); Molecular Medicine (Q4)"
277;67938;Journal of Social and Administrative Pharmacy;journal;02810662;0.256;Q2;20;37;95;687;41;90;0.35;18.57;Sweden;Western Europe;Swedish Pharmaceutical Press;1962, 1986-2003;"Leadership and Management (Q2); Pharmaceutical Science (Q2)"
278;20104;CNS Drug Reviews;journal;1080563X, 15273458;0.254;Q3;61;24;96;2478;60;96;0.61;103.25;United States;Northern America;Neva Press, Inc.;1995-2007;"Neuropsychology and Physiological Psychology (Q3); Pharmacology (Q3)"
279;21354;Expert Opinion on Therapeutic Targets;journal;14728222, 17447631;0.254;Q3;94;47;135;5636;70;135;0.75;119.91;United Kingdom;Western Europe;Taylor and Francis Ltd.;1997-2021;"Clinical Biochemistry (Q3); Pharmacology (Q3); Drug Discovery (Q4); Molecular Medicine (Q4)"
280;79053;Natural Product Sciences;journal;12263907;0.253;Q4;28;27;126;424;33;126;0.14;15.7;South Korea;Asiatic Region;Korean Society of Pharmacognosy;1997-2021;"Drug Discovery (Q4); Organic Chemistry (Q4)"
281;130063;Pharmacological Reports;journal;17341140;0.249;Q3;87;88;194;2607;133;193;0.77;29.63;Netherlands;Western Europe;Elsevier BV;2005-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
282;12328;Current Therapeutic Research;journal;0011393X, 18790313;0.248;Q3;42;86;279;2284;149;235;0.57;26.56;United States;Northern America;Elsevier Inc.;1959-2021;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
283;21100241807;Artificial Cells, Nanomedicine and Biotechnology;journal;2169141X, 21691401;0.245;Q2;57;37;215;787;122;204;0.73;21.27;United States;Northern America;Informa Healthcare;2013-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Biomedical Engineering (Q3); Biotechnology (Q3)"
284;21077;Pharmaca;journal;00316857;0.242;Q3;5;12;29;446;7;29;0.38;37.17;Croatia;Eastern Europe;Udruzenje Organizacija Zdravstva Hrvatske;1989-2011;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
285;21100389517;Drug Metabolism and Personalized Therapy;journal;23638907, 23638915;0.241;Q2;36;16;65;713;45;64;0.75;44.56;Germany;Western Europe;Walter de Gruyter GmbH;2015-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
286;20664;Current Drug Targets;journal;18735592, 13894501;0.238;Q3;107;29;21;3384;16;21;0.76;116.69;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2000-2021;"Clinical Biochemistry (Q3); Pharmacology (Q3); Drug Discovery (Q4); Molecular Medicine (Q4)"
287;37381;In Vitro and Molecular Toxicology: Journal of Basic and Applied Research;journal;10979336;0.238;Q3;21;23;97;659;55;86;0.53;28.65;United States;Northern America;Mary Ann Liebert Inc.;1996-2001;"Toxicology (Q3); Health, Toxicology and Mutagenesis (Q4)"
288;20051;BioDrugs;journal;11738804, 1179190X;0.237;Q3;71;70;230;4783;142;218;0.58;68.33;United Kingdom;Western Europe;Adis International Ltd;1997-2021;"Medicine (miscellaneous) (Q2); Biotechnology (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
289;19405;Acta Poloniae Pharmaceutica;journal;00016837;0.235;Q2;45;80;291;1387;70;291;0.23;17.34;Poland;Eastern Europe;Polish Pharmaceutical Society;1951-1955, 1961-2021;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
290;21350;Expert Opinion on Emerging Drugs;journal;14728214, 17447623;0.233;Q3;51;23;70;2173;60;68;0.89;94.48;United Kingdom;Western Europe;Taylor and Francis Ltd.;2000-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
291;25149;Journal of Toxicological Sciences;journal;18803989, 03881350;0.233;Q3;53;39;244;832;88;244;0.41;21.33;Japan;Asiatic Region;Japanese Society of Toxicological Sciences;1976-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q3)"
292;21102;Pharmaceutical Journal;journal;00316873;0.232;Q2;28;901;1036;1740;114;480;0.11;1.93;United Kingdom;Western Europe;Pharmaceutical Press;1945-1949, 1994-2012, 2014-2017;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
293;20083;British Journal of Clinical Pharmacology, Supplement;journal;02643774;0.231;Q2;32;18;12;649;25;11;0;36.06;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1998, 2000-2004;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
294;19383;Fluoride - Quarterly Reports;journal;22534083, 00154725;0.231;Q3;48;26;92;531;46;72;0.46;20.42;New Zealand;Pacific Region;International Society for Fluoride Research;1973-2021;"Agricultural and Biological Sciences (miscellaneous) (Q2); Chemistry (miscellaneous) (Q3); Dentistry (miscellaneous) (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3); Biochemistry (Q4); Health, Toxicology and Mutagenesis (Q4)"
295;23348;Journal of Environmental Biology;journal;23940379, 02548704;0.231;Q3;51;62;201;1086;36;195;0.19;17.52;India;Asiatic Region;Triveni Enterprises;1988-2021;"Environmental Engineering (Q3); Toxicology (Q3); Health, Toxicology and Mutagenesis (Q4)"
296;19927;Methods and Findings in Experimental and Clinical Pharmacology;journal;03790355;0.231;Q3;53;85;357;2000;214;357;0.66;23.53;Spain;Western Europe;Prous Science;1979-2010;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
297;24097;Journal of the Indian Chemical Society;journal;00194522;0.23;Q4;33;171;533;4492;186;532;0.36;26.27;India;Asiatic Region;Elsevier BV;1973-1985, 1987-1991, 1996-2021;"Drug Discovery (Q4); Electrochemistry (Q4); Inorganic Chemistry (Q4); Organic Chemistry (Q4); Physical and Theoretical Chemistry (Q4)"
298;15340;Developments in Biologicals;journal;14246074, 16622960;0.227;Q3;38;76;55;149;22;55;0.4;1.96;Switzerland;Western Europe;S. Karger AG;2000-2008, 2010, 2012-2013;"Pharmacology (Q3); Biomaterials (Q4); Immunology (Q4)"
299;54408;Pharmacy and Pharmacology Communications;journal;14608081;0.225;Q2;25;0;354;0;169;350;0.46;0;United Kingdom;Western Europe;Pharmaceutical Press;1993, 1995, 1998-2000;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
300;75047;Current Opinion in Anti-inflammatory and Immunomodulatory Investigational Drugs;journal;14648474;0.22;Q3;5;0;35;0;15;30;0.43;0;United Kingdom;Western Europe;Current Drugs Ltd.;2000;"Pharmacology (Q3); Immunology (Q4)"
301;21328;European Journal of Drug Metabolism and Pharmacokinetics;journal;21070180, 03787966;0.22;Q3;39;38;169;896;114;165;0.57;23.58;France;Western Europe;Springer Paris;1976-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
302;25245;Veterinary and Human Toxicology;journal;01456296;0.22;Q3;41;98;333;1574;208;313;0.62;16.06;United States;Northern America;Comparative Toxicology Laboratories;1977-2004;"Toxicology (Q3); Veterinary (miscellaneous) (Q3); Health, Toxicology and Mutagenesis (Q4)"
303;79249;Modern Drug Discovery;journal;10998209;0.219;Q2;9;19;45;85;26;45;0.56;4.47;United States;Northern America;American Chemical Society;1998-2001;Pharmaceutical Science (Q2)
304;145580;International Journal of Peptide Research and Therapeutics;journal;15733149, 15733904;0.217;Q4;38;51;267;1375;104;264;0.43;26.96;Netherlands;Western Europe;Springer Netherlands;1996-2002, 2005-2021;"Analytical Chemistry (Q4); Biochemistry (Q4); Bioengineering (Q4); Drug Discovery (Q4); Molecular Medicine (Q4)"
305;19444;American Journal of Pharmaceutical Education;journal;15536467, 00029459;0.216;Q2;69;60;214;968;65;214;0.32;16.13;United States;Northern America;American Association of Colleges of Pharmacy;1945-1948, 1973-1989, 1991, 1996-2021;"Medicine (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Education (Q3)"
306;21256;Drugs of Today;journal;00257656, 16993993, 16994019;0.215;Q3;53;113;337;4381;196;333;0.6;38.77;Spain;Western Europe;Prous Science;1968, 1978-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q3); Pharmacology (medical) (Q3)"
307;23089;Journal of Pharmacy and Pharmaceutical Sciences;journal;14821826;0.214;Q2;81;22;49;724;30;43;0.77;32.91;Canada;Northern America;Canadian Society for Pharmaceutical Sciences;1998-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (Q3)"
308;22392;Indian Journal of Pharmaceutical Sciences;journal;0250474X, 19983743;0.213;Q2;61;120;285;513;42;284;0.14;4.28;India;Asiatic Region;Wolters Kluwer Medknow Publications;1978-2021;Pharmaceutical Science (Q2)
309;21715;Pharmazeutische Industrie;journal;16167074, 0031711X;0.213;Q2;19;212;607;1446;74;593;0.14;6.82;Germany;Western Europe;Editio Cantor Verlag GmbH;1960-1961, 1973-2019;Pharmaceutical Science (Q2)
310;19381;Acta Farmaceutica Bonaerense;journal;03262383;0.211;Q2;0;0;0;0;0;0;0;0;Argentina;Latin America;Colegio de Farmaceuticos de la Provincia de Buenos Aires;1989-2006;"Pharmaceutical Science (Q2); Drug Discovery (Q4)"
311;25253;Blutalkohol (discontinued);journal;00065250;0.21;Q3;13;23;103;491;27;103;0.27;21.35;Germany;Western Europe;Steintor-Verlag GmbH;1974-2017, 2020-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q3)"
312;4700152903;Forensic Toxicology;journal;18608965, 18608973;0.208;Q3;39;31;118;410;28;118;0.21;13.23;Japan;Asiatic Region;Springer Japan;2006-2021;"Biochemistry (medical) (Q3); Pathology and Forensic Medicine (Q3); Toxicology (Q3)"
313;22212;Scientia Pharmaceutica;journal;22180532, 00368709;0.208;Q2;46;38;105;718;31;104;0.35;18.89;Switzerland;Western Europe;MDPI AG;1949, 1960-1961, 1973-2021;Pharmaceutical Science (Q2)
314;130031;Journal of Toxicologic Pathology;journal;09149198;0.206;Q4;30;48;107;1055;48;107;0.52;21.98;Japan;Asiatic Region;Japanese Society of Toxicologic Pathology;1988-1990, 1992-2021;"Pathology and Forensic Medicine (Q3); Toxicology (Q4)"
315;20065;BioPharm International;trade journal;1542166X, 19391862;0.204;Q2;29;136;305;666;60;264;0.22;4.9;United States;Northern America;Advanstar Communications Inc.;2002-2020;"Pharmaceutical Science (Q2); Biotechnology (Q3)"
316;35190;Revista Espanola de Quimioterapia;journal;02143429;0.196;Q3;26;40;149;1360;56;131;0.39;34;Spain;Western Europe;Sociedad Espanola de Quiminoterapia;1989-2021;"Medicine (miscellaneous) (Q2); Microbiology (medical) (Q3); Pharmacology (Q3)"
317;21496;Revista de Chimie (discontinued);journal;00347752;0.194;-;31;141;400;1633;55;400;0.13;11.58;Romania;Eastern Europe;Syscom 18 SRL;1973, 1996-2021;Chemistry (miscellaneous) (Q3)
318;20564;Ceska a Slovenska Farmacie;journal;12107816;0.191;Q3;17;52;165;1549;31;163;0.2;29.79;Czech Republic;Eastern Europe;Czech Medical Association J.E. Purkyne;1994-2021;Pharmaceutical Science (Q3)
319;21800;Farmacevtski Vestnik (discontinued);journal;00148229;0.191;Q3;4;23;193;565;12;193;0.07;24.57;Slovenia;Eastern Europe;Slovenian Pharmaceutical Society;1961, 1989-2016;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
320;21246;International Journal of Immunopathology and Pharmacology;journal;03946320;0.191;Q3;58;23;70;857;36;69;0.68;37.26;Italy;Western Europe;SAGE Publications Inc.;1989-2021;"Pharmacology (Q3); Immunology (Q4); Immunology and Allergy (Q4)"
321;25111;International Journal of Toxicology;journal;10915818, 1092874X;0.191;Q4;62;80;196;2812;57;182;0.2;35.15;United States;Northern America;SAGE Publications Inc.;1982-2021;Toxicology (Q4)
322;22411;Inflammopharmacology;journal;09254692, 15685608;0.19;Q3;55;30;88;1117;44;88;0.51;37.23;Switzerland;Western Europe;Birkhauser Verlag Basel;1991-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3); Immunology (Q4)"
323;26370;Molecules;journal;14203049;0.189;Q3;171;172;473;2653;105;468;0.23;15.42;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);1992, 1996-2021;"Medicine (miscellaneous) (Q2); Chemistry (miscellaneous) (Q3); Pharmaceutical Science (Q3); Analytical Chemistry (Q4); Drug Discovery (Q4); Molecular Medicine (Q4); Organic Chemistry (Q4); Physical and Theoretical Chemistry (Q4)"
324;22435;International Journal of Clinical Pharmacology Research;journal;02511649;0.188;Q3;31;17;50;444;55;50;1.36;26.12;Switzerland;Western Europe;Bioscience Ediprint Inc.;1981-2005;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
325;9500153932;Ciencia y Tecnologia Pharmaceutica;journal;15753409;0.187;Q3;6;31;60;478;23;60;0.53;15.42;Spain;Western Europe;Fundacion Alimentacion Saludable;1996-2007;Pharmacology (Q3)
326;22881;Yaoxue Xuebao;journal;05134870;0.187;Q3;34;223;619;2339;118;619;0.16;10.49;China;Asiatic Region;Chinese Pharmaceutical Association;1960, 1962-1966, 1979-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Molecular Medicine (Q4)"
327;25144;Journal of Health Science;journal;13475207, 13449702;0.186;Q4;49;91;187;2181;82;187;0.44;23.97;Japan;Asiatic Region;Pharmaceutical Society of Japan;1999-2011;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
328;4000148019;AAPS Journal;journal;15507416;0.185;Q3;118;72;101;2219;63;101;0.62;30.82;United States;Northern America;Springer New York;1999-2021;Pharmaceutical Science (Q3)
329;20679;Current Opinion in Investigational Drugs;journal;20403429, 14724472;0.185;Q3;79;36;0;1888;0;0;0;52.44;United Kingdom;Western Europe;Current Drugs Ltd.;2000-2010;"Medicine (miscellaneous) (Q2); Pharmacology (Q3); Drug Discovery (Q4)"
330;21718;Pharmazie in Unserer Zeit;journal;00483664, 16151003;0.185;Q3;13;79;78;955;36;78;0.44;12.09;Germany;Western Europe;Wiley-VCH Verlag;1972-2012;"Pharmaceutical Science (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
331;15581;Current Pharmaceutical Biotechnology;journal;13892010, 18734316;0.184;Q3;88;29;23;2659;17;23;0.74;91.69;Netherlands;Western Europe;Bentham Science Publishers B.V.;2000-2021;"Pharmaceutical Science (Q3); Biotechnology (Q4)"
332;20599;Paediatric and Perinatal Drug Therapy;journal;14630095;0.183;Q3;19;18;38;381;15;34;0.41;21.17;United Kingdom;Western Europe;Librapharm;1997-2008;"Pediatrics, Perinatology and Child Health (Q3); Pharmacology (Q3)"
333;25196;Revista Brasileira de Toxicologia;journal;14152983;0.182;Q4;7;18;9;402;1;8;0.11;22.33;Brazil;Latin America;Sociedade Brasileira de Toxicologia;2000-2010;Toxicology (Q4)
334;21716;Pharmazeutische Zeitung;journal;00317136;0.18;Q3;7;439;1761;1384;32;1207;0.01;3.15;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1947-1948, 1985-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
335;52550;Pharmacology and Toxicology, Supplement;journal;09019936;0.179;Q3;7;0;47;0;16;46;0.27;0;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1990-2000;"Pharmacology (Q3); Toxicology (Q4)"
336;24659;Comments on Toxicology;journal;08865140;0.178;Q4;12;20;44;789;12;30;0.48;39.45;United Kingdom;Western Europe;Taylor and Francis Ltd.;1995-2003;Toxicology (Q4)
337;34232;Toxicology Methods;journal;10517235;0.178;Q4;18;21;69;610;22;69;0.28;29.05;United Kingdom;Western Europe;Taylor and Francis Ltd.;1993-2001;Toxicology (Q4)
338;16893;Biogenic Amines;journal;15693910, 01688561;0.176;Q3;15;33;98;1025;37;97;0.31;31.06;Slovenia;Eastern Europe;Society of Integrated Sciences;1989-2007;"Pharmacology (Q3); Neuroscience (miscellaneous) (Q4)"
339;19398;Acta Pharmaceutica;journal;18469558, 13300075;0.175;Q3;60;36;104;669;20;104;0.23;18.58;Croatia;Eastern Europe;Croatian Pharmaceutical Society;1986, 1992-2022;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q3); Pharmacology (Q3)"
340;23277;Acta Physiologica Pharmacologica et Therapeutica Latinoamericana;journal;03276309;0.175;Q3;13;0;66;0;24;65;0.21;0;Argentina;Latin America;Association Latinoamericana de Ciencias Fisiologicas;1991-1999;"Pharmacology (Q3); Physiology (Q4)"
341;4700152769;Pharmacopeial Forum (discontinued);journal;03634655;0.174;Q3;19;9;41;184;11;41;0.08;20.44;United States;Northern America;United States Pharmacopeial Convention Inc.;1996-1998, 2000-2018;"Pharmacy (Q1); Drug Guides (Q2); Pharmacology (Q3)"
342;66652;Toxic Substance Mechanisms;journal;10769188;0.172;Q4;12;0;49;0;14;45;0.32;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;1995-2000;"Pollution (Q3); Toxicology (Q4)"
343;21264;Drugs in R and D;journal;11796901, 11745886;0.17;Q3;47;0;240;0;76;240;0.32;0;United Kingdom;Western Europe;Adis International Ltd;1999, 2002-2008, 2010-2021;Pharmacology (Q3)
344;5000158117;Profiles of Drug Substances, Excipients and Related Methodology;journal;18715125;0.167;Q3;21;20;24;1058;8;22;0.27;52.9;United States;Northern America;Academic Press Inc.;2001-2003, 2005, 2007-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
345;23440;Indian Journal of Physiology and Pharmacology;journal;00195499;0.166;Q3;53;76;269;1757;68;222;0.21;23.12;India;Asiatic Region;Association of Physiologists and Pharmacologists of India;1959-2021;"Pharmacology (Q3); Physiology (Q4); Physiology (medical) (Q4)"
346;88338;Journal of Pharmacoepidemiology;journal;08966966;0.166;Q3;4;0;11;0;1;9;0.09;0;United States;Northern America;"John Wiley &amp; Sons Inc.";1991, 1994-2000;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
347;22393;Indian Journal of Pharmacology;journal;02537613, 19983751;0.165;Q3;62;84;243;1475;59;194;0.21;17.56;India;Asiatic Region;Wolters Kluwer Medknow Publications;1978-1980, 1982, 1984-1986, 1994-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
348;76262;Journal of Venomous Animals and Toxins;journal;01047930;0.165;Q4;0;0;0;0;0;0;0;0;Brazil;Latin America;Centro de Estudos de Venenos e Animais Peconhentos;1996-1998;Toxicology (Q4)
349;23171;Korean Journal of Pharmacognosy;journal;02533073;0.165;Q3;17;43;141;748;16;141;0.14;17.4;South Korea;Asiatic Region;Korean Society of Pharmacognosy;1990-2011, 2013-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
350;91481;Pharmacology Reviews and Communications;journal;10288945;0.165;Q3;9;26;43;777;15;43;0.24;29.88;United Kingdom;Western Europe;Taylor and Francis Ltd.;1996-2002;Pharmacology (Q3)
351;19374;AAPS PharmSciTech;journal;15309932;0.162;Q3;101;36;40;601;20;38;0.5;16.69;Switzerland;Western Europe;Springer International Publishing AG;2000-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q3); Agronomy and Crop Science (Q4); Aquatic Science (Q4); Drug Discovery (Q4); Ecology (Q4); Ecology, Evolution, Behavior and Systematics (Q4)"
352;21811;Farmacia Hospitalaria;journal;21718695, 11306343;0.162;Q3;24;39;167;730;24;142;0.11;18.72;Spain;Western Europe;Grupo Aula Medica S.A.;1990-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
353;22854;Yakugaku Zasshi;journal;13475231, 00316903;0.162;Q3;43;101;267;3312;124;266;0.45;32.79;Japan;Asiatic Region;Pharmaceutical Society of Japan;1961-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
354;21795;Farmaceuticky Obzor (discontinued);journal;00148172;0.161;Q3;7;28;78;486;8;78;0.15;17.36;Slovakia;Eastern Europe;Postgraduate Medical and Pharmaceutical School;1961-1963, 1974, 1976-2016;Pharmaceutical Science (Q3)
355;21840;Folia Pharmacologica Japonica;journal;00155691, 13478397;0.161;Q3;19;121;350;2729;78;322;0.14;22.55;Japan;Asiatic Region;Japanese Pharmacological Society;1944, 1947-1948, 1951-1956, 1958-2021;Pharmacology (Q3)
356;23009;Journal of Clinical Research;journal;13695207;0.161;Q3;11;10;56;233;17;56;0.25;23.3;United Kingdom;Western Europe;PJB Publications Ltd.;1998-2009;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
357;58672;Prescribers' Journal;journal;00327611;0.161;Q3;6;0;110;0;24;80;0.3;0;United Kingdom;Western Europe;Her Majesty's Stationery Office;1970, 1973-2000;Pharmaceutical Science (Q3)
358;22357;IDrugs : the investigational drugs journal;journal;13697056, 20403410;0.159;Q3;35;54;310;4189;71;306;0.21;77.57;United Kingdom;Western Europe;Current Drugs Ltd.;1998-2010;"Medicine (miscellaneous) (Q2); Pharmacology (Q3); Drug Discovery (Q4)"
359;25425;Journal of Herbs, Spices and Medicinal Plants;journal;15403580, 10496475;0.159;Q3;29;25;92;1096;32;90;0.17;43.84;United States;Northern America;Taylor and Francis Ltd.;1992-2021;"Complementary and Alternative Medicine (Q3); Pharmacology (Q3)"
360;97159;Journal of Research in Pharmaceutical Economics;journal;08966621;0.159;Q3;5;30;26;611;6;25;0;20.37;United States;Northern America;Pharmaceutical Products Press;1996-1998, 2000-2001;"Health Policy (Q3); Pharmaceutical Science (Q3)"
361;29845;IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer;book series;10171606;0.158;Q4;48;23;183;4580;51;183;0.28;199.13;France;Western Europe;International Agency for Research on Cancer;1988-1997, 1999-2002, 2004, 2006-2008, 2010-2020;"Cancer Research (Q4); Toxicology (Q4)"
362;72164;Journal of Infectious Disease Pharmacotherapy;journal;10687777;0.158;Q3;6;27;29;776;6;28;0.17;28.74;United States;Northern America;Pharmaceutical Products Press;1996, 1998-1999, 2001-2004;"Microbiology (medical) (Q3); Pharmacology (Q3)"
363;22338;Hospital Pharmacy;journal;19451253, 00185787;0.156;Q4;24;166;474;1625;84;399;0.19;9.79;United States;Northern America;Thomas Land Publishers Inc.;1973-2021;"Pharmacy (Q2); Pharmacology (medical) (Q3); Pharmacology (Q4)"
364;25110;International Journal of Medical Toxicology and Legal Medicine;journal;09720448;0.154;Q4;9;14;23;127;1;22;0.04;9.07;India;Asiatic Region;All India Institute of Medical Sciences;1999-2003, 2005-2011, 2017-2021;"Pathology and Forensic Medicine (Q3); Toxicology (Q4)"
365;21813;Research Communications in Alcohol and Substances of Abuse;journal;10808388;0.149;Q4;5;4;20;111;6;20;0.42;27.75;United States;Northern America;PJD Publications Ltd;1994-1999, 2001;"Medicine (miscellaneous) (Q3); Toxicology (Q4)"
366;21867;Geneesmiddelenbulletin;journal;03044629;0.148;Q4;7;72;277;216;19;46;0.09;3;Netherlands;Western Europe;Stichting Geneesmiddelenbulletin;1973-2021;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
367;25197;Revista de Toxicologia (discontinued);journal;02127113;0.147;Q4;11;17;51;304;9;51;0.13;17.88;Spain;Western Europe;Asociacion Espanola de Toxicologia;1989-2017, 2020;Toxicology (Q4)
368;19982;Asia Pacific Journal of Pharmacology;journal;02179687;0.146;Q4;9;18;49;416;7;47;0.04;23.11;Singapore;Asiatic Region;Singapore University Press;1986-1998, 2000-2001, 2003-2004, 2006;Pharmacology (Q4)
369;21758;Prescrire International;journal;11677422;0.145;Q4;13;101;254;1321;56;240;0.24;13.08;France;Western Europe;Association Mieux Prescrire;1996-2021;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
370;22205;Saudi Pharmaceutical Journal;journal;13190164;0.145;Q3;57;27;84;1055;12;77;0.17;39.07;Saudi Arabia;Middle East;King Saud University;1996-2021;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
371;19700174971;Indian Journal of Forensic Medicine and Toxicology (discontinued);journal;09739122, 09739130;0.144;Q4;12;0;0;0;0;0;0;0;India;Asiatic Region;Institute of Medico-legal Publications;2008-2021;"Law (Q3); Health, Toxicology and Mutagenesis (Q4); Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
372;19700189100;Pharmaceutical Medicine;journal;11782595, 11791993;0.142;Q4;19;60;196;684;44;129;0.24;11.4;United Kingdom;Western Europe;Adis International Ltd;2000-2001, 2008-2021;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
373;18800156720;Dissolution Technologies;journal;1521298X;0.141;Q3;34;13;44;70;17;24;0.52;5.38;United States;Northern America;Dissolution Technologies Inc;1996-2021;Pharmaceutical Science (Q3)
374;66831;Proceedings of the Controlled Release Society;journal;10220178;0.141;Q3;14;0;1102;0;129;1102;0.12;0;United States;Northern America;Controlled Release Society, Inc.;1993-1999;Pharmaceutical Science (Q3)
375;25247;Chinese Journal of Pharmacology and Toxicology;journal;10003002;0.14;Q4;12;91;266;1197;40;262;0.18;13.15;China;Asiatic Region;Chinese Journal of Pharmacology and Toxicology;1986-2020;"Pharmacology (Q4); Toxicology (Q4)"
376;17716;Quality Assurance Journal;journal;10991786, 10878378;0.139;Q3;9;25;57;118;3;52;0.09;4.72;United Kingdom;Western Europe;John Wiley and Sons Ltd;1998, 2000-2007, 2009-2011;"Medicine (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
377;18098;Japanese Journal of Psychopharmacology;journal;13402544;0.137;Q4;0;0;0;0;0;0;0;0;Japan;Asiatic Region;Japanese Society of Neuropsychopharmacology;1981-2016;"Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3); Clinical Psychology (Q4); Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
378;21127;Pharmaceutical Technology Europe;journal;01646826;0.135;Q3;18;73;249;363;41;187;0.17;4.97;United States;Northern America;Advanstar Communications Inc.;1998-2020;Pharmaceutical Science (Q3)
379;23173;Korean Journal of Physiology and Pharmacology;journal;20933827, 12264512;0.133;Q4;33;62;225;2118;36;225;0.18;34.16;South Korea;Asiatic Region;Korean Physiological Soc. and Korean Soc. of Pharmacology;1997-2021;"Pharmacology (Q4); Physiology (Q4)"
380;19399;Acta Pharmaceutica Hungarica (discontinued);journal;00016659;0.132;Q3;14;56;110;1403;14;110;0.11;25.05;Hungary;Eastern Europe;Magyar Gyogyszereszeti Tarsasag;1965-2018;"Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3)"
381;22934;Chinese Pharmaceutical Journal;journal;10012494;0.132;Q3;21;287;818;2541;61;817;0.06;8.85;China;Asiatic Region;Chinese Pharmaceutical Association;1993-2021;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
382;21866;Gazi Universitesi Eczacilik Fakultesi Dergisi;journal;10159592;0.131;Q3;8;21;30;299;5;30;0.18;14.24;Turkey;Middle East;Gazi Universitesi;1984-2003;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
383;19700180737;Pharmacochemistry Library;journal;01657208;0.131;Q4;10;0;64;0;15;36;0;0;Netherlands;Western Europe;Elsevier;1995-1998, 2000, 2002;"Drug Discovery (Q4); Organic Chemistry (Q4); Pharmacology (Q4)"
384;21142;Pharmaceutisch Weekblad;journal;00316911;0.129;Q4;9;401;1519;3013;95;1133;0.07;7.51;Netherlands;Western Europe;Kon. Ned. Mij. ter Bevordering der Pharmacie (KNMP);1948-2021;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
385;22825;Proceedings of the Western Pharmacology Society;journal;00838969;0.129;Q4;24;65;311;782;50;310;0.16;12.03;United States;Northern America;Western Pharmacology Society;1960-1969, 1973-2011;Pharmacology (Q4)
386;38938;Japanese Journal of Toxicology and Environmental Health;journal;0013273X;0.128;Q4;12;0;109;0;30;108;0.41;0;Japan;Asiatic Region;Pharmaceutical Society of Japan;1958-1961, 1963-1999;Toxicology (Q4)
387;4800154015;S.T.P. Pharma Pratiques;journal;11571497;0.126;Q3;10;37;125;143;13;123;0.1;3.86;France;Western Europe;Editions de Sante;1991-2014, 2017-2018;Pharmaceutical Science (Q3)
388;19461;Annales Pharmaceutiques Francaises;journal;00034509;0.125;Q3;27;51;179;1119;46;168;0.22;21.94;France;Western Europe;Elsevier Masson s.r.l.;1945, 1947-2021;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
389;19484;Antibiotics and chemotherapy;journal;00664758, 16622863;0.125;Q4;8;0;19;0;8;19;0.44;0;Switzerland;Western Europe;S. Karger AG;1956, 1964-1965, 1968-1971, 1974-1976, 1978-1983, 1985, 1987-1989, 1991-1992, 1994-1996, 1998, 2000;"Medicine (miscellaneous) (Q3); Pharmacology (Q4)"
390;79257;Antiinfective Drugs and Chemotherapy;journal;09464832;0.125;Q4;6;0;29;0;6;24;0.5;0;Germany;Western Europe;Futuramed Publishers Gmbh;1994-1998, 2000;Pharmacology (Q4)
391;19700182901;Brazilian Journal of Pharmaceutical Sciences;journal;19848250, 21759790;0.125;Q3;43;42;85;1242;11;82;0.1;29.57;Brazil;Latin America;Faculdade de Ciencias Farmaceuticas (Biblioteca-;2009-2020;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
392;19408;Actualites Pharmaceutiques;journal;05153700;0.124;Q4;5;53;197;462;5;184;0.03;8.72;Netherlands;Western Europe;Elsevier;1961, 1963, 1996-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
393;130016;Cutaneous and Ocular Toxicology;journal;15569527, 15569535;0.124;Q4;32;27;128;1630;17;109;0.1;60.37;United Kingdom;Western Europe;Informa Healthcare;1982-2000, 2005-2021;"Medicine (miscellaneous) (Q3); Toxicology (Q4)"
394;78698;Japanese Journal of Clinical Pharmacology and Therapeutics;journal;18828272, 03881601;0.124;Q4;7;43;465;314;6;465;0.01;7.3;Japan;Asiatic Region;Japanese Society of Clinical Pharmacology and Therapeutics;1970-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
395;62531;Pharmaceutical News;journal;1071894X;0.124;Q3;11;72;29;894;6;24;0.21;12.42;United Kingdom;Western Europe;Taylor and Francis Ltd.;2000-2002;Pharmaceutical Science (Q3)
396;21826;Revista Brasileira de Farmacia;journal;0370372X;0.124;Q3;9;0;69;0;6;69;0.03;0;Brazil;Latin America;Associacao Brasileira De Farmaceuticos;1945, 1984-2000;Pharmaceutical Science (Q3)
397;21814;Research Communications in Pharmacology and Toxicology;journal;10871101;0.123;Q4;7;26;47;579;8;47;0.23;22.27;United States;Northern America;PJD Publications Ltd;1997-2003;"Pharmacology (Q4); Toxicology (Q4)"
398;21837;Revista Portuguesa de Farmacia;journal;0484811X;0.123;Q3;5;21;65;677;3;65;0.05;32.24;Portugal;Western Europe;Ordem dos Farmaceuticos;1961, 1990-2001;Pharmaceutical Science (Q3)
399;21100239606;Therapeutic Innovation and Regulatory Science;journal;21684790, 21684804;0.123;Q3;46;241;775;3805;255;762;0.31;15.79;United States;Northern America;SAGE Publications Inc.;1970, 1972, 1974-2006, 2008-2011, 2013-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Pharmacology (medical) (Q4); Public Health, Environmental and Occupational Health (Q4)"
400;23085;Journal of Pharmacological Sciences;journal;13478648, 13478613;0.121;Q4;87;0;0;0;0;0;0;0;Japan;Asiatic Region;Japanese Pharmacological Society;1996-2021;"Molecular Medicine (Q4); Pharmacology (Q4)"
401;25241;Toxicology Mechanisms and Methods;journal;15376524, 15376516;0.121;Q4;46;0;0;0;0;0;0;0;United Kingdom;Western Europe;Informa Healthcare;1991-2021;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
402;19700175108;Drug Delivery System;journal;18812732, 09135006;0.12;Q4;8;35;114;825;11;114;0.13;23.57;Japan;Asiatic Region;Japan Society of Drug Delivery System;1986, 1988-2021;Pharmaceutical Science (Q4)
403;21227;Pharmacy in Practice;journal;13581538;0.119;Q4;5;25;70;141;5;40;0.08;5.64;United Kingdom;Western Europe;Medicom Publishing;1995-2009;"Pharmacy (Q3); Health Policy (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
404;60295;Acta Technologiae et Legis Medicamenti;journal;11212098;0.118;Q4;5;0;25;0;2;25;0.1;0;Italy;Western Europe;Maccari Editore Srl;1995-1999;Pharmaceutical Science (Q4)
405;69108;Chemotherapie Journal, Supplement;journal;09446486;0.118;Q4;6;17;28;352;6;27;0.21;20.71;Germany;Western Europe;Wissenschaftliche Verlagsgesellschaft Stuttgart;1996-1997, 1999-2003;"Microbiology (medical) (Q4); Pharmacology (Q4)"
406;20627;Clinical Research and Regulatory Affairs;journal;15322521, 10601333;0.117;Q4;17;23;49;1132;6;46;0.11;49.22;United States;Northern America;Informa Healthcare;1983-1990, 1992-2016;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
407;22979;Journal of Applied Therapeutic Research;journal;10292659;0.117;Q4;8;0;51;0;3;51;0.04;0;United Kingdom;Western Europe;Euromed Communications;1998-2000, 2003-2012;Pharmacology (Q4)
408;13718;Pharmaceutical Engineering;journal;02738139;0.117;Q4;16;34;138;292;10;131;0.07;8.59;United States;Northern America;Int. Society for Pharmaceutical Engineering, Inc.;1996-2018;Pharmaceutical Science (Q4)
409;22908;Chinese Pharmacological Bulletin;journal;10011978;0.116;Q4;17;230;532;2620;24;532;0.05;11.39;China;Asiatic Region;Institute of Clinical Pharmacology;1993-2020;Pharmacology (Q4)
410;70864;Anales de la Real Academia Nacional de Farmacia (discontinued);journal;1697428X, 16974271;0.115;Q4;10;3;34;215;3;34;0.04;71.67;Spain;Western Europe;Real Academia Nacional de Farmacia;1988-2018;"Cell Biology (Q4); Molecular Biology (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
411;22937;Zhongguo Zhongyao Zazhi;journal;10015302;0.115;Q3;32;155;467;1127;17;466;0.03;7.27;China;Asiatic Region;Zhongguo Zhongyi Yanjiuyuan;1989-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Complementary and Alternative Medicine (Q4); Pharmacology (medical) (Q4)"
412;19407;Acta Poloniae Toxicologica;journal;12306967;0.114;Q4;4;22;53;480;3;53;0.06;21.82;Poland;Eastern Europe;Polskie Towarzystwo Toksykologiczne/Polish Society of Toxicology;1999-2002;Toxicology (Q4)
413;19459;Ankara Universitesi Eczacilik Fakultesi Dergisi;journal;10153918;0.113;Q4;11;12;32;402;3;32;0.05;33.5;Turkey;Middle East;University of Ankara;1997-2001, 2003-2010, 2014, 2016-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
414;24605;Arhiv za Higijenu Rada i Toksikologiju;journal;18486312, 00041254;0.113;Q4;37;40;102;961;18;99;0.15;24.03;Croatia;Eastern Europe;Institute for Medical Research and Occupational Health;1953-2021;"Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
415;15240;Iranian Journal of Medical Sciences;journal;17353688, 02530716;0.113;-;31;12;37;239;2;35;0.1;19.92;Iran;Middle East;Shiraz University of Medical Sciences;1979-1981, 1989-2021;Medicine (miscellaneous) (Q3)
416;27715;Anil Aggrawal's Internet Journal of Forensic Medicine and Toxicology;journal;09728074, 09728066;0.112;Q4;11;19;17;151;1;13;0.06;7.95;India;Asiatic Region;Anil Aggrawal;2000-2020;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
417;21279;Eksperimental'naya i Klinicheskaya Farmakologiya;journal;08692092;0.112;Q4;15;145;460;2642;22;460;0.04;18.22;Russian Federation;Eastern Europe;Izdatelstvo Meditsina;1992-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q4); Toxicology (Q4)"
418;21374;Fabad Journal of Pharmaceutical Sciences;journal;13004182;0.112;Q4;18;26;51;954;5;51;0.1;36.69;Turkey;Middle East;Society of Pharmaceutical Sciences of Ankara;1999-2001, 2003-2021;Pharmaceutical Science (Q4)
419;19700182122;Pharmaceuticals Policy and Law;journal;2210495X, 13892827;0.112;Q4;10;26;17;121;2;16;0.12;4.65;Netherlands;Western Europe;IOS Press BV;1999, 2001-2002, 2005, 2007-2018;"Health Policy (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
420;20572;PZ Prisma;journal;09455566;0.112;Q4;5;28;95;946;4;84;0.03;33.79;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1994-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
421;72763;Drugs Made in Germany;journal;00126683;0.111;Q4;4;16;44;206;2;35;0;12.88;Germany;Western Europe;Editio Cantor Verlag GmbH;1960-1964, 1973-2002;"Molecular Medicine (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
422;21292;Epitheorese Klinikes Farmakologias kai Farmakokinetikes;journal;10116575;0.111;Q4;5;5;35;191;2;35;0.09;38.2;Bulgaria;Eastern Europe;PHARMAKON-Press;1989-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
423;22977;Journal de Pharmacie de Belgique;journal;00472166;0.111;Q4;12;20;399;409;16;398;0.17;20.45;Belgium;Western Europe;APB Algemene Pharmaceutische Bond;1946-2015;"Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
424;5700165173;Journal of Medical Marketing;journal;17457912, 17457904;0.111;Q4;19;31;28;327;1;25;0.04;10.55;United States;Northern America;SAGE Publications Inc.;2000-2015, 2017-2018;"Medicine (miscellaneous) (Q3); Marketing (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4); Strategy and Management (Q4)"
425;21836;Revista Mexicana de Ciencias Farmaceuticas;journal;10273956;0.111;Q4;9;27;82;482;2;70;0.02;17.85;Mexico;Latin America;Asociacion Farmaceutica Mexicana A.C.;1997-2015;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
426;17700156431;Handbook of Analytical Separations;book series;15677192;0.11;Q4;12;12;43;1223;3;38;0.07;101.92;Netherlands;Western Europe;Elsevier;2000-2001, 2003-2004, 2008, 2020;"Analytical Chemistry (Q4); Environmental Chemistry (Q4); Pathology and Forensic Medicine (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
427;22354;IDMA Bulletin;journal;09706054;0.11;Q4;1;0;8;0;0;2;0;0;India;Asiatic Region;Indian Drug Manufacturers' Association;1997-1999;"Health Policy (Q4); Pharmacology (Q4)"
428;110141;Sangyo eiseigaku zasshi = Journal of occupational health;journal;13410725;0.108;Q4;14;15;60;150;7;60;0.11;10;Japan;Asiatic Region;Nihon Sangyo Eisei Gakkai;1995-2021;"Medicine (miscellaneous) (Q3); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
429;23284;Acta Physiologica et Pharmacologica Bulgarica;journal;03239950;0.107;Q4;15;42;43;0;5;43;0.12;0;Bulgaria;Eastern Europe;Universitetsko Izdatelstvo Sv. Kliment Okhridski/Publishing House of the Sofia University St. Kilment Ohridski;1974-1996, 1998-2001, 2003;"Pharmacology (Q4); Physiology (Q4)"
430;21797;Farmaceutisch Tijdschrift voor Belgie;journal;07712367;0.107;Q4;3;17;45;256;1;43;0;15.06;Belgium;Western Europe;APB Algemene Pharmaceutische Bond;1978-2013;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
431;19430;Adverse Drug Reaction Bulletin;journal;21597774, 00446394;0.106;Q4;7;6;18;150;4;18;0.25;25;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1970, 1973-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
432;21238;Drug Topics;journal;19378157, 00126616;0.106;Q4;8;321;1796;0;44;1283;0.03;0;United States;Northern America;Advanstar Communications Inc.;1991, 1997-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
433;22514;Japanese Journal of Chemotherapy;journal;13407007;0.106;Q4;12;66;221;1139;9;221;0.03;17.26;Japan;Asiatic Region;Japan Society of Chemotherapy;1995-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
434;19700180827;Progress in Pharmaceutical and Biomedical Analysis;book series;14643456;0.106;Q4;8;0;49;0;2;47;0.04;0;United Kingdom;Western Europe;Elsevier Ltd.;1994, 1996, 2000, 2003, 2005;"Biochemistry (Q4); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Biomedical Engineering (Q4); Biotechnology (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
435;17744;Anales de la Real Academia Nacional de Medicina;journal;00340634;0.105;Q4;6;45;129;598;4;129;0.01;13.29;Spain;Western Europe;Real Academia de Farmacia;1949-2012, 2014;"Cell Biology (Q4); Medicine (miscellaneous) (Q4); Molecular Biology (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
436;54564;Antimicrobics and Infectious Diseases Newsletter;journal;1069417X;0.105;Q4;5;0;38;0;2;36;0;0;Netherlands;Western Europe;Elsevier BV;1994-1998, 2000, 2002;"Microbiology (medical) (Q4); Pharmacology (Q4)"
437;59522;Current Therapeutics;journal;0311905X;0.105;Q4;5;100;199;1065;7;199;0.04;10.65;Australia;Pacific Region;ADIS Press;1974-1988, 1992, 1994, 1996-2002;Pharmacology (Q4)
438;22858;Japanese Pharmacology and Therapeutics;journal;03863603;0.105;Q4;16;123;781;1598;19;778;0.02;12.99;Japan;Asiatic Region;Life Science Publishing Co. Ltd;1981-2020;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
439;5800207507;Side Effects of Drugs Annual;book series;03786080;0.105;Q4;6;51;153;3328;6;153;0.06;65.25;Netherlands;Western Europe;Elsevier;1977-1995, 1997-2005, 2007-2012, 2014-2020;"Drug Guides (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
440;23107;Journal of Pharmacy Technology;journal;15494810, 87551225;0.104;Q4;13;54;145;598;8;89;0.07;11.07;United States;Northern America;SAGE Publications Inc.;1989-2021;Pharmaceutical Science (Q4)
441;13637;Manufacturing Chemist;trade journal;02624230;0.104;Q4;6;906;791;137;9;141;0.01;0.15;United Kingdom;Western Europe;Wilmington Publishing;1981-1984, 1986, 1989, 1996-2001, 2006-2021;Pharmaceutical Science (Q4)
442;21086;Pharmaceutical Chemistry Journal;journal;15739031, 0091150X;0.104;Q4;34;187;491;2945;11;489;0.03;15.75;United States;Northern America;Springer New York;1967-2021;"Drug Discovery (Q4); Pharmacology (Q4)"
443;20543;Pharmacometrics;journal;03008533;0.104;Q4;6;18;67;284;9;67;0.05;15.78;Japan;Asiatic Region;Japanese Society of Pharmacometrics;1973-2004, 2009-2012;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
444;4700152283;Revista de Ciencias Farmaceuticas Basica e Aplicada;journal;18084532;0.104;Q4;18;8;25;268;1;25;0;33.5;Brazil;Latin America;Universidade Estadual Paulista - UNESP;2005-2021;Pharmaceutical Science (Q4)
445;88685;Annual Report of Shionogi Research Laboratory;journal;05598680;0.103;Q4;2;1;6;87;0;6;0;87;Japan;Asiatic Region;Shionogi Co. Ltd;1972-1974, 1987-2009, 2015;Pharmacology (Q4)
446;35042;Ciencia Pharmaceutica;journal;11315253;0.103;Q4;2;0;6;0;0;6;0;0;Spain;Western Europe;Alpe Editores;1991-1998;Pharmacology (Q4)
447;37682;Gyogyszereszet;journal;00176036;0.103;Q4;2;0;47;0;1;47;0.04;0;Hungary;Eastern Europe;Magyar Gyogyszereszeti Tarsasag;1960-1962, 1973-1985, 1988-2000;Pharmacology (Q4)
448;22457;International Pharmacy Journal;journal;10100423;0.103;Q4;4;0;131;0;3;107;0.01;0;Netherlands;Western Europe;International Pharamaceutical Federation/Federation Internationale Pharmaceutique;1987-1999;Pharmaceutical Science (Q4)
449;89630;Psychopharmakotherapie, Supplement;journal;09465146;0.103;Q4;2;0;7;0;0;5;0;0;Germany;Western Europe;Wissenschaftliche Verlagsgesellschaft Stuttgart;1997-1999, 2004-2005, 2007-2008;"Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
450;26767;Altex;journal;1868596X, 18688551;0.102;Q4;57;41;29;196;3;27;0.1;4.78;Germany;Western Europe;Springer International Publishing AG;2000-2021;"Medical Laboratory Technology (Q4); Medicine (miscellaneous) (Q4); Pharmacology (Q4)"
451;20710;DARU, Journal of Pharmaceutical Sciences;journal;15608115, 20082231;0.102;Q4;47;19;9;333;0;9;0;17.53;United Kingdom;Western Europe;BioMed Central Ltd.;2000-2021;"Drug Discovery (Q4); Medicine (miscellaneous) (Q4); Pharmacology (Q4)"
452;20778;EOS Rivista di Immunologia ed Immunofarmacologia;journal;03926699;0.102;Q4;5;8;67;320;13;65;0.05;40;Italy;Western Europe;Sigma-Tau SpA;1983-2001, 2003-2004;"Immunology (Q4); Pharmacology (Q4)"
453;5200152602;Acta Pharmaceutica Sciencia;journal;13072080;0.101;Q4;20;36;99;737;18;99;0.13;20.47;Turkey;Middle East;Istanbul Medipol University;2006-2011, 2016-2021;Pharmaceutical Science (Q4)
454;19978;Ars Pharmaceutica (discontinued);journal;00042927;0.101;Q4;20;15;73;40;2;73;0.02;2.67;Spain;Western Europe;Universidad de Granada;1980-1981, 1983-1984, 1986-2001, 2003-2017, 2021;"History and Philosophy of Science (Q4); Pharmaceutical Science (Q4)"
455;145693;Canadian Pharmacists Journal;journal;17151635;0.101;Q4;24;120;344;569;12;222;0.04;4.74;Canada;Northern America;Canadian Pharmacists Association;2005-2021;"Pharmaceutical Science (Q4); Pharmacy (Q4)"
456;19900191748;Clin-Alert;journal;1530812X, 00694770;0.101;Q4;0;0;24;0;0;24;0;0;United States;Northern America;Science Editors;1996-1998;"Pharmacology (Q4); Toxicology (Q4)"
457;21100239829;Current Issues in Pharmacy and Medical Sciences;journal;2084980X;0.101;Q4;10;0;0;0;0;0;0;0;Poland;Eastern Europe;Uniwersytet Medyczny w Lublinie;2012-2021;"Biochemistry (Q4); Medicine (miscellaneous) (Q4); Molecular Biology (Q4); Pharmacology (Q4)"
458;21932;Hindustan Antibiotics Bulletin;journal;00181935;0.101;Q4;9;0;19;0;1;19;0;0;India;Asiatic Region;Hindustan Antibiotics Ltd.;1960-1961, 1965-2000, 2002-2003, 2005, 2007, 2009;Pharmacology (Q4)
459;94365;Journal of Phytomedicine and Therapeutics;journal;11181028;0.101;Q4;6;22;14;303;0;14;0;13.77;Nigeria;Africa;National Institute for Pharmaceutical Research and Development;2000-2003, 2007, 2009, 2015-2016;Pharmacology (Q4)
460;23169;Klinische Pharmakologie Aktuell;journal;09395164;0.101;Q4;3;0;52;0;2;35;0.07;0;Germany;Western Europe;W.Zuckschwerdt Verlag GmbH;1995-2000;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
461;67942;Lyon Pharmaceutique;journal;00247804;0.101;Q4;3;0;37;0;2;35;0;0;France;Western Europe;Association des Pharmaciens - Anciens Eleves - Amis de la Faculte de Pharmacie de Lyon;1961, 1975, 1984, 1993-1998;Pharmaceutical Science (Q4)
462;63556;Pharmacie Hospitaliere Francaise;journal;03699579;0.101;Q4;4;0;112;0;4;110;0.04;0;France;Western Europe;Syndicat des Pharmaciens Gerants;1982-2000;Pharmaceutical Science (Q4)
463;72755;Phytomedica;journal;09723293;0.101;Q4;4;15;27;220;2;26;0.07;14.67;India;Asiatic Region;Society of Phytomedica;1999-2008;"Complementary and Alternative Medicine (Q4); Pharmacology (Q4)"
464;16698;Revista Brasileira de Plantas Medicinais;journal;1983084X, 15160572;0.101;Q4;29;23;28;449;1;25;0.04;19.52;Brazil;Latin America;Instituto de Biociencias;1999-2016;"Complementary and Alternative Medicine (Q4); Pharmacology (Q4)"
465;20133;Therapie und Erfolg;journal;1433111X;0.101;Q4;1;0;42;0;0;31;0;0;Germany;Western Europe;G Braun Buchverlag;1998;Pharmacology (Q4)
466;9500153934;Therapiewoche;journal;02566869;0.101;Q4;1;25;37;45;0;30;0;1.8;Austria;Western Europe;Therapiewoche Verlag;2000-2002;Pharmacology (Q4)
467;74999;American Druggist;journal;01905279;0.1;Q4;3;0;109;0;1;85;0;0;United States;Northern America;Hearst Corp;1946-1949, 1983-1999;Pharmaceutical Science (Q4)
468;22887;Chinese Journal of Antibiotics;journal;10018689;0.1;Q4;11;146;459;1077;6;420;0.01;7.38;China;Asiatic Region;Editorial Office of Chinese Journal of Antibiotics;1983-2015;Pharmacology (Q4)
469;20628;Circular Farmaceutica;journal;00097314;0.1;Q4;3;31;155;222;0;129;0;7.16;Spain;Western Europe;Col-legi de Farmaceutics de la Provincia de Barcelona;1961, 1973-2020;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
470;21798;Farmaceutski Glasnik;journal;00148202;0.1;Q4;6;12;98;232;1;98;0;19.33;Croatia;Eastern Europe;Hrvatsko Farmaceutsko Drustvo;1950-1951, 1962, 1990-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
471;15680;Giornale di Neuropsicofarmacologia;journal;19711387, 03919048;0.1;Q4;1;19;67;224;0;67;0;11.79;Italy;Western Europe;CIC Edizioni Internazionali s.r.l.;1996-2008;"Neurology (clinical) (Q4); Neuropsychology and Physiological Psychology (Q4); Neuroscience (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
472;21907;Journal of Anaesthesiology Clinical Pharmacology;journal;09709185, 22312730;0.1;Q4;35;0;207;0;4;170;0.02;0;India;Asiatic Region;Wolters Kluwer Medknow Publications;1996-1999, 2002-2021;"Anesthesiology and Pain Medicine (Q4); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
473;86349;Oral Therapeutics and Pharmacology;journal;02881012;0.1;Q4;5;17;66;366;0;66;0;21.53;Japan;Asiatic Region;Japanese Society of Oral Therapeutics and Pharmacology;1982-2021;"Dentistry (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
474;63560;Pharmaceutical Visions;journal;09661719;0.1;Q4;1;28;153;70;0;57;0;2.5;United Kingdom;Western Europe;London Monarch Communications;1997-2001;Pharmaceutical Science (Q4)
475;21823;Pharmacia;journal;04280296;0.1;Q4;16;11;64;215;2;64;0.03;19.55;Bulgaria;Eastern Europe;Pensoft Publishers;1945, 1954-1955, 1987-1991, 1997-2021;"Pharmaceutical Science (Q4); Pharmacology (medical) (Q4); Pharmacy (Q4)"
476;21828;Revista Cubana de Farmacia;journal;00347515, 15612988;0.1;Q4;9;0;41;0;1;41;0.03;0;Cuba;Latin America;Editorial Ciencias Medicas;1980-1991, 1996-2000, 2002, 2004-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
477;5100152903;Revista Cubana de Plantas Medicinales;journal;10284796;0.1;Q4;14;18;48;274;1;48;0.02;15.22;Cuba;Latin America;Editorial Ciencias Medicas;1996-1997, 1999-2002, 2005-2020;"Drug Discovery (Q4); Pharmacology (Q4); Plant Science (Q4)"
478;36238;Therapiewoche Schweiz;journal;02566869;0.1;Q4;1;0;99;0;1;90;0.02;0;Switzerland;Western Europe;Therapiewoche Verlag;1990-2000;Pharmacology (Q4)
479;21687;American Journal of PharmacoGenomics;journal;11752203;;-;38;29;0;2215;0;0;0;76.38;United Kingdom;Western Europe;Adis International Ltd;2001-2005;"Genetics; Molecular Medicine; Pharmacology"
480;29318;Anti-Cancer Agents in Medicinal Chemistry;journal;18715206, 18755992;;-;100;18;0;2221;0;0;0;123.39;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Cancer Research; Molecular Medicine; Pharmacology"
481;61687;Antiviral Chemistry and Chemotherapy, Supplement;journal;13502816;;-;11;17;0;1305;0;0;0;76.76;Switzerland;Western Europe;World Health Organization;1993-1995, 1997, 2001;"Pharmacology; Virology"
482;16836;BMC Chemical Biology;journal;14726769;;-;20;4;0;143;0;0;0;35.75;United Kingdom;Western Europe;BioMed Central Ltd.;2001-2012;"Drug Discovery; Molecular Medicine"
483;20026;BMC Clinical Pharmacology;journal;14726904;;-;39;4;0;98;0;0;0;24.5;United Kingdom;Western Europe;BioMed Central Ltd.;2001-2012;"Pharmacology; Pharmacology (medical)"
484;20027;BMC Pharmacology;journal;14712210;;-;44;13;0;532;0;0;0;40.92;United Kingdom;Western Europe;BioMed Central Ltd.;2001-2012;"Pharmacology; Pharmacology (medical)"
485;4600151526;Cardiovascular and Hematological Disorders - Drug Targets;journal;1871529X;;-;42;8;0;945;0;0;0;118.13;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Cardiology and Cardiovascular Medicine; Hematology; Medicine (miscellaneous); Molecular Medicine; Pharmacology"
486;22575;Cardiovascular Toxicology;journal;15307905, 15590259;;-;56;34;0;758;0;0;0;22.29;United States;Northern America;Humana Press;2001-2021;"Cardiology and Cardiovascular Medicine; Molecular Biology; Toxicology"
487;29311;Current Cancer Drug Targets;journal;15680096, 18735576;;-;96;16;0;1772;0;0;0;110.75;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Cancer Research; Drug Discovery; Pharmacology"
488;22072;Current Gene Therapy;journal;18755631, 15665232;;-;75;24;0;2797;0;0;0;116.54;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Drug Discovery; Genetics; Genetics (clinical); Molecular Biology; Molecular Medicine"
489;20681;Current Opinion in Pharmacology;journal;14714973, 14714892;;-;139;92;0;4567;0;0;0;49.64;Netherlands;Western Europe;Elsevier BV;2001-2021;"Drug Discovery; Pharmacology"
490;21100198011;Current Protocols in Pharmacology;journal;19348282, 19348290;;-;34;59;0;0;0;0;0;0;United States;Northern America;"John Wiley &amp; Sons Inc.";2001-2020;"Medicine (miscellaneous); Pharmacology"
491;19700188399;Current protocols in toxicology / editorial board, Mahin D. Maines (editor-in-chief) ... [et al.];journal;19349254, 19349262;;-;28;90;0;0;0;0;0;0;United States;Northern America;"John Wiley &amp; Sons Inc.";2001-2020;"Medicine (miscellaneous); Toxicology"
492;12331;Current Topics in Medicinal Chemistry;journal;15680266, 18734294;;-;122;40;0;3529;0;0;0;88.23;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Drug Discovery; Medicine (miscellaneous)"
493;21100938253;Environmental Pollutants and Bioavailability;journal;26395940, 26395932;;-;33;13;43;408;24;43;0.63;31.38;United Kingdom;Western Europe;Taylor and Francis Ltd.;2019-2021;"Chemical Health and Safety; Health, Toxicology and Mutagenesis; Toxicology"
494;21329;European Journal of Herbal Medicine;journal;13524755;;-;2;14;0;321;0;0;0;22.93;United Kingdom;Western Europe;National Institute of Medical Herbalists Ltd;2001-2004;Pharmacology
495;13250;Expert Opinion on Biological Therapy;journal;14712598, 17447682;;-;91;84;0;6963;0;0;0;82.89;United Kingdom;Western Europe;Taylor and Francis Ltd.;2001-2021;"Clinical Biochemistry; Drug Discovery; Pharmacology"
496;4600151527;Infectious Disorders - Drug Targets;journal;18715265;;-;55;27;0;2515;0;0;0;93.15;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous); Microbiology (medical); Molecular Medicine; Pharmacology"
497;22432;International Immunopharmacology;journal;18781705, 15675769;;-;119;199;0;9446;0;0;0;47.47;Netherlands;Western Europe;Elsevier;2001-2021;"Immunology; Immunology and Allergy; Pharmacology"
498;15842;Journal of Applied Research;journal;1537064X;;-;22;18;0;439;0;0;0;24.39;United States;Northern America;The Journal of Applied Research;2001-2014;"Medicine (miscellaneous); Pharmacology; Pharmacology (medical)"
499;35452;Journal of Autonomic Pharmacology;journal;01441795;;-;26;35;130;1075;92;130;0.69;30.71;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1980-2001;"Neuroscience (miscellaneous); Pharmacology"
500;63982;Journal of Cannabis Therapeutics;journal;15299775, 15299783;;-;16;14;0;670;0;0;0;47.86;United States;Northern America;Haworth Integrative Healing Press;2001-2004;Pharmacology
501;27767;Journal of Forensic Medicine and Toxicology;journal;09711929;;-;18;18;88;173;6;87;0.07;9.61;India;Asiatic Region;;1997-2020;"Pathology and Forensic Medicine; Toxicology"
502;26653;Journal of Herbal Pharmacotherapy;journal;15229106, 15228940;;-;29;31;0;911;0;0;0;29.39;United States;Northern America;The Haworth Herbal Press;2001-2008;"Biochemistry; Pharmacology"
503;21281;Journal of Immunotherapy;journal;10538550;;-;46;31;74;988;189;74;2.13;31.87;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1991-2004;"Cancer Research; Immunology; Pharmacology"
504;19900191564;Journal of International Peacekeeping;journal;18754104, 18754112;;-;10;25;0;1264;0;0;0;50.56;Netherlands;Western Europe;Brill Academic Publishers;1995, 1997, 2001, 2004-2006, 2008-2011, 2013-2021;"Infectious Diseases; Pharmacology; Pharmacology (medical); Virology"
505;94039;Journal of Managed Pharmaceutical Care;journal;15349721, 15349713;;-;3;35;0;452;0;0;0;12.91;United States;Northern America;Pharmaceutical Products Press;2001;"Leadership and Management; Pharmacology"
506;21100874234;Latin American Journal of Pharmacy;journal;23623853, 03262383;;-;26;44;123;961;22;122;0.17;21.84;Argentina;Latin America;Colegio de Farmaceuticos de la Provincia de Buenos Aires;2007-2021;"Drug Discovery; Pharmaceutical Science"
507;24797;Mini-Reviews in Medicinal Chemistry;journal;18755607, 13895575;;-;95;38;0;3149;0;0;0;82.87;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Drug Discovery; Medicine (miscellaneous); Pharmacology"
508;4200151509;Molecular Diagnosis and Therapy;journal;11771062;;-;47;1;0;55;0;0;0;55;United Kingdom;Western Europe;Adis International Ltd;2001, 2004, 2006-2021;"Genetics; Medicine (miscellaneous); Molecular Medicine; Pharmacology"
509;21100862294;Neuropsychopharmacology Reports;journal;2574173X;;-;14;28;111;670;20;108;0.15;23.93;United States;Northern America;"John Wiley &amp; Sons Inc.";2018-2021;"Clinical Psychology; Pharmacology; Pharmacology (medical); Psychiatry and Mental Health"
510;18071;Neurotoxicity Research;journal;14763524, 10298428;;-;78;45;1;2485;0;1;0;55.22;United States;Northern America;Springer New York;1999, 2001-2021;"Neuroscience (miscellaneous); Toxicology"
511;21083;Pharmaceutical Care Espana (discontinued);journal;11396202;;-;9;51;0;596;0;0;0;11.69;Spain;Western Europe;Fundacion Pharamaceutical Care Espana;2001-2017;"Pharmaceutical Science; Pharmacology; Pharmacy"
512;21168;Pharmacogenomics Journal;journal;1470269X, 14731150;;-;90;56;0;190;0;0;0;3.39;United Kingdom;Western Europe;Nature Publishing Group;2001-2021;"Genetics; Molecular Medicine; Pharmacology"
513;34348;Teratogenesis Carcinogenesis and Mutagenesis;journal;02703211;;-;40;43;101;1435;97;99;0.97;33.37;United States;Northern America;"John Wiley &amp; Sons Inc.";1980-2003;"Genetics; Genetics (clinical); Health, Toxicology and Mutagenesis; Oncology; Toxicology"
514;38272;Teratology;journal;00403709;;-;73;79;297;2484;387;241;1.37;31.44;United States;Northern America;"John Wiley &amp; Sons Inc.";1968-2002;"Developmental Biology; Embryology; Health, Toxicology and Mutagenesis; Toxicology"
